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Abstract 
Gastrointestinal nematodes cause significant morbidity and mortality in sheep. 
Anthelmintics are essential for worm management, but the sole reliance on these drugs to 
manage infections has led to widespread anthelmintic resistance (AR). Ivermectin is the 
only anthelmintic licenced for use in sheep in Canada, although off-label use of 
benzimidazoles and levamisole is common. In Nova Scotia during 2012, many farmers 
reported sheep deaths due to worms, despite anthelmintic treatment, and there is no 
information about AR in Eastern Canada. Haemonchus contortus has become the most 
problematic species in Nova Scotia. Closantel, a narrow spectrum drug that kills only H. 
contortus, was accessed through the Emergency Drug Release process. AR was 
investigated through Fecal Egg Count Reduction Tests on 13 farms over the grazing 
seasons of 2013 and 2014. Resistance to ivermectin, moxidectin, benzimidazoles, and 
levamisole was found on 5/6, 0/1, 6/7, and 0/8 farms, respectively. Post-treatment larval 
cultures showed that H. contortus was resistant to ivermectin and benzimidazoles, 
whereas closantel was effective against H. contortus and provided adequate worm control 
for several weeks. Levamisole was effective, but its short duration of activity necessitated 
more frequent treatments. Albendazole in combination with closantel was highly 
effective against all species, and drug combinations offer a means to extend the useful 
lifetime of both drugs. Seasonal monitoring showed a high peak in lamb infection levels 
in July-August of 2013 and 2014. Grazing lambs with and without ewes was investigated 
in 2014. Lambs grazed without ewes did not require treatment, whereas lambs grazed 
with ewes required treatment at the end of August. This grazing strategy may be an 
appealing and cost effective option to limit infections with H. contortus. To ensure the 
sustainability of sheep production in Nova Scotia, a transition to using anthelmintic 
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Gastrointestinal nematodes (GIN) of sheep belong to the superfamilies 
Strongyloidea and Trichostrongyloidea (Roeber et al. 2013). GIN cause significant 
morbidity and mortality in sheep, and these health effects along with the costs of 
pharmacologic treatment reduce the profitability of sheep farming. Anthelmintics are 
essential for GIN management, but the sole reliance on these drugs to manage infections 
has led to widespread anthelmintic resistance (AR) in Europe (Papadopoulos et al. 2012), 
Australia (Leathwick and Besier 2014), New Zealand (Waghorn et al. 2006; Leathwick 
2014), and North and South America (Falzon et al. 2013b; Torres-Acosta et al. 2012). 
The development of AR is influenced by many factors, including: the life cycle and 
epidemiology of GIN, the availability of refugia populations, the timing and frequency of 
treatment, and the quarantine of incoming animals (Abbott et al. 2012).   
1.1 Species and life cycle  
In Canada, as in other countries, there are several common species of GIN that 
parasitize sheep. The highly pathogenic species are Haemonchus contortus, Teladorsagia 
circumcincta, Trichostrongylus spp., and Nematodirus battus. Other less pathogenic 
species include: Chabertia ovina, Strongyloides papillosus, Nematodirus filicollis, 
Cooperia spp., Bunostomum spp., Trichuris ovis, and Oesophagostomum spp. (Mederos 
et al. 2010; University of Guelph 2012). The location of GIN in the digestive tract of 
sheep is species specific. H. contortus, T. circumcincta, and Trichostrongylus axei live in 
the abomasum; Trichostrongylus colubriformis, Trichostrongylus vitrinus, and N. battus 
live in the small intestine (University of Guelph 2012). The fecundity of these species 
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varies greatly. H. contortus is the most prolific, and a single female is capable of 
producing up to 10 000 eggs per day. Female N. battus produce around 50 eggs per day, 
and Trichostrongylus spp. and T. circumcincta produce a few hundred egg daily (Abbott 
et al. 2012; Roeber et al. 2013). 
Almost all GIN have a similar direct life cycle, with both free living and parasitic 
stages. Adult GIN live in the gastrointestinal tract, and females lay eggs which are passed 
in the feces (Fig. 1). A first stage larva (L1) develops within the egg, hatches, and feeds 
on bacteria within the feces (Abbott et al. 2012). The L1 moults to the second stage larva 
(L2), which also feeds on bacteria. The L2 moults to the infective third stage larva (L3), 
but retains its L2 cuticle as a sheath, which protects the L3 from desiccation, but prevents 
feeding. L3s migrate out of the feces and onto forage where they are eaten by grazing 
sheep. Within the gastrointestinal tract, the L3 casts off its sheath and moults to a fourth 
stage larva (L4), which undergoes a final moult to an immature adult (L5). L4s and adults 
are parasitic and feed on the sheep. After maturing, adults reproduce, and females begin 





Figure 1. Life cycle of gastrointestinal nematode parasites of sheep. Image modified 
from: R. Betts 2012. 
H. contortus is a sub-tropical species that has expanded its range to temperate 
climates (Waller and Chandrawathani 2005). This species is a relatively new problem in 
Nova Scotia. It was not identified in a previous study of GIN infections in 1997 (Maal-
Bared 1998), but it is now ubiquitous on sheep farms (Jones 2013). Likewise, H. 
contortus has become prevalent in Central Canada (Mederos et al. 2010). H. contortus is 
the most pathogenic species of GIN in sheep, and unlike other species, even healthy adult 
sheep are at risk of illness from H. contortus in the summer because enormous numbers 
of L3s on pasture can overwhelm the sheep’s acquired immunity (Abbott et al. 2012). H. 
contortus has a tooth to puncture the abomasal mucosa, and it feeds on blood (Angulo-
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Cubillán et al. 2007). Each worm can consume 0.05mL of blood per day, and a burden of 
500 worms can cause clinical illness. As a prolific breeder, each generation of H. 
contortus creates a huge effective population size and vast genetic diversity on which 
anthelmintic selection can act. Based on the mutation rate of Caenorhabditis elegans, 500 
adult female H. contortus could produce enough offspring, per day, for a new mutation to 
occur at every nucleotide in the nuclear genome (Gilleard 2013). As a consequence of the 
high egg output, and the fact that larvae overwinter only in sheep and not on pasture, H. 
contortus can rapidly develop resistance to anthelmintics (Waller et al. 2004; Groz et al. 
2013).  
N. battus has a slightly different life cycle and epidemiology from most GIN. N. 
battus is an Arctic species (Hoberg 2005) that develops to a L3 inside the egg before 
hatching in the following spring, and disease transmission is from one year’s batch of 
lambs to the next (Winter 2002). Typically, hatching is triggered by an increase in soil 
temperatures over 11C in the spring, after eggs have overwintered on pasture (van Dijk 
and Morgan 2010). In the United Kingdom, a rapid increase in temperatures leads to 
mass hatches (National Animal Disease Information Service 2014).  Lambs become 
infected, but develop immunity within a few weeks and expel adult worms (Israf et al. 
1997). Immunity is age related, with older sheep maintaining their immunity and 
preventing the establishment of N. battus larvae. In contrast to other species, egg-laying 
adults do not cause significant disease. The emergence of immature adult worms from the 
intestinal mucosa causes damage to this tissue, resulting in lack of appetite and diarrhea, 
prior to the beginning of egg laying (Abbott et al. 2012). Hence, severe nematodirosis can 
occur before eggs are detected in the feces. N. battus continues to be a severe problem in 
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the United Kingdom (Morgan & van Dijk 2012), but this parasite is not considered 
prevalent in central Canada (University of Guelph 2012), and although it is prevalent in 
Nova Scotia, N. battus does not seem to cause significant health problems (Jones 2013). 
The long generation time and low egg output of N. battus are thought to be the reasons 
why AR has rarely been documented in this species, despite decades of exposure to 
anthelmintics (Mitchell et al. 2011).  
1.2 Seasonal patterns 
Pastures are considered contaminated when GIN eggs and/or free living larvae are 
present. Pastures are considered infective when L3s are present and environmental 
conditions are suitable for disease transmission (Abbott et al. 2012). In the spring, peri-
parturient ewes are the main source of pasture contamination. Ewe immunity wanes 
around lambing, and hypobiotic larvae resume development, which leads to an increase 
in egg shedding known as the peri-parturient egg rise (Blitz and Gibbs 1972; Beasly et al. 
2010; Falzon et al. 2013a). In the summer and fall, lambs are the main source of pasture 
contamination. Larval development on pasture is temperature (Reynecke et al. 2012) and 
moisture dependent, with higher temperatures and moist conditions accelerating 
development (Morgan and van Dijk 2012). Eggs laid early in the spring, when 
temperatures are lower, can take 10-12 weeks to develop to L3s. Eggs laid later in the 
year, when temperatures are higher, can develop to L3s in one to two weeks (Abbott et al. 
2012). Under optimal conditions, H. contortus can become infective in just five days 
(University of Guelph 2012). Warm and dry periods reduce the survival of eggs and early 
stage larvae, but not L3s (Eysker et al. 2005), and for dry periods of about a week, fecal 
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pellets can act as a moist reservoir for larvae (Wang et al. 2014). Pastures can go from 
highly contaminated to highly infective over a few weeks, and pasture contamination and 
infectivity peak in late summer (Mederos et al. 2010). Lambs grazing on contaminated 
pasture can be overwhelmed by high larval challenge, and they can become severely 
affected quickly.   
In temperate climates such as in Canada, there are two possible ways by which 
infective larvae can survive the winter when environmental conditions are not favourable 
for the completion of the GIN life cycle: they can survive freezing temperatures on 
pasture, or inside the sheep as hypobiotic larvae. Hypobiosis is an environmentally 
induced state of arrested development, similar to diapause in insects (Sommerville and 
Davey 2002). Overwinter survival of H. contortus L3s on pasture is minimal in cold 
winter climates (Waller et al. 2004; Troell et al. 2005; Groz et al. 2013), so that survival 
from one grazing season to the next occurs primarily as hypobiotic larvae inside sheep. 
By contrast, T. circumcincta, Trichostrongylus spp., and N. battus all overwinter as both 
hypobiotic larvae and on pasture (Smith & Fulton 1989; Thomas 1991; Waller et al. 
2004). Thus, for these species, a large pool of L3s remains on pasture at the beginning of 
the next grazing season and can infect sheep at turn-out. 
GIN larvae that undergo hypobiosis halt development as early-stage L4s, inside the 
gastrointestinal mucosa (Sommerville and Davey 2002). The mechanisms for how 
hypobiosis is initiated, sustained, and terminated are not well understood. Environmental 
conditions such as temperature and photoperiod, as well as host immunity and magnitude 
of worm burden have all been implicated as factors involved. A Canadian study on out-
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of-season lambing concluded that environmental and host immunological factors 
contribute to the entry and exit of H. contortus from hypobiosis (Falzon et al. 2013a). 
Typically, hypobiosis begins in late autumn or early winter, although it is unknown when 
hypobiosis begins in Canada, and there is probably regional variation in the onset and 
extent of hypobiosis, as has been observed in other countries with temperate climates 
(Capitini et al. 1990; Miller et al. 1998).  
Under field conditions, GIN infections involve more than one species, but the 
contribution of different species to infections in lambs varies over the grazing season. 
Early in the season, infections are from species that overwintered on pasture. Infection 
levels then rise over the summer, as large numbers of eggs shed by peri-parturient ewes 
develop to L3s. H. contortus becomes the biggest contributor to worm burdens in mid to 
late summer (Miller et al. 1998; Jones 2013). In late summer and early fall H. contortus 
still predominates, but T. circumcincta and Trichongylus spp. begin to contribute more to 
worm burdens. These two genera produce far fewer eggs, relative to H. contortus, so it 
takes longer for sheep to pick up significant numbers of L3s. In Canada, GIN infections 
in lambs peak from August to October, and pasture management strategies and weather 
patterns influence the timing of the peak from year to year (Maal-Bared 1997; Mederos et 
al. 2010; Betts 2014). 
1.3 Monitoring infections 
Pasture raised adult sheep have acquired immunity to GIN and are usually able to 
manage their worm burdens well, without treatment. However, when immunity wanes, 
around parturition and lactation, some ewes may need treatment (Falzon et al. 2014a). 
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Immunity is never 100%, and continued exposure to GIN is needed to maintain 
immunity. In their first grazing season, it takes lambs or sheep four to six months to 
develop a good immune response to GIN, and anthelmintic treatment is often necessary 
to restore health and to ensure the survival of these animals (Abbott et al. 2012). 
Subclinical infections of GIN cause reduced weight gains and clinical infections result in 
lack of appetite, weight loss, diarrhea, sub-mandibular oedema (bottle-jaw), anemia, and 
in severe cases, death. Diarrhea is a common sign of GIN infection, but H. contortus 
causes anemia and constipation, which can mask this sign even when other species are 
abundant (University of Guelph 2012). 
Clinical symptoms can be subjectively assessed with Body Condition scores (fatness), 
Dag scores (fecal soiling of hindquarters), and FAMACHA scores (Abbott et al. 2012). 
Named after its creator, Dr. Faffa Malan (FAffa Malan CHArt), the FAMACHA 
system was designed to monitor the anemia caused by H. contortus (van Wyk and Bath 
2002; Kaplan et al. 2004). With this system, anemia is ranked on a five point scale based 
on the pinkness of the lower eyelid mucosa by comparison with a simple color chart. A 
score of four or five indicates serious anemia, which requires treatment. Subjective 
monitoring methods can be conducted quickly, on the farm, and with minimal training 
farmers can use the FAMACHA system to correctly identify sheep suffering from 
haemonchosis (Burke et al. 2007; Maia et al. 2014). Yet, on their own, these methods are 
not reliable predictors of total GIN burden because there are many causes for diarrhea 
and weight loss, and anemia is an indicator of infections with only H. contortus (Mederos 
et al. 2014; Williams and Palmer 2012). To make treatment decisions, subjective methods 
need to be used in conjunction with fecal egg count(s) (FEC).  
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FEC are expressed as eggs per gram of feces (epg), and they are the most common 
method by which to gauge GIN burdens. Briefly, to calculate FEC, feces are mixed with 
a flotation solution and a small volume of this mixture is transferred to the two chambers 
of a McMaster counting slide (Ballweber et al. 2014). Eggs float to the top of the 
chambers and debris sinks to the bottom. Both chambers are etched with a grid. Eggs 
within the grids are counted, and the sum is multiplied by the dilution factor to give the 
epg. Whether a FEC is considered high depends on the species contributing to the count. 
According to Abbott et al’s. (2012) guide for interpreting FEC, pathogenic levels of 
infection may be indicated by 500epg of N. battus and 1500epg in mixed infections, but 
5000epg or more if H. contortus is the predominant species (Table A1). 
With an adequate number of samples, mean FEC reflect the overall pattern of 
infection within a flock. At least 10 samples are essential because GIN infections are 
over-dispersed, with a few sheep having high worm burdens and the majority of sheep 
having low worm burdens (Morgan et al. 2005). Due to this pattern, too few samples are 
likely to underestimate the FEC in highly parasitized sheep. These results could 
incorrectly indicate that sheep do not need treatment, when in fact they do. Based on 
FEC, decisions can be made to treat the whole flock, or a portion of the flock. Normally, 
lambs have higher mean FEC than those of older sheep, so only lambs may need 
treatment. In Nova Scotia, few farms use FEC to monitor GIN infections – cost is the 
main inhibiting factor. For a registered farm each FEC costs around $6, and for an 
unregistered farm each FEC costs about $13 through the Department of Agriculture or as 
much as $20 through a veterinarian (Jones, personal communication 2014).  
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1.4 Anthelmintic resistance 
Anthelmintic resistance (AR) is defined as the heritable loss of sensitivity in a worm 
population to a drug that was previously effective (Köhler 2001). AR is inevitable with 
repeated use of a drug that fails to kill the entire population of GIN in treated animals. In 
every GIN population there are a few individuals that carry alleles for resistance to drug 
treatment (Gilleard and Beech 2007). After treatment, these resistant individuals have a 
reproductive advantage, as it takes two to three weeks for newly picked up L3s to 
develop into egg-laying adults. Resistance builds up insidiously, and during this period 
there is still a clinical response to anthelmintics. As resistance increases further, sheep 
weight gains may be reduced and farmers may need to treat sheep within shorter intervals 
(Sargison et al. 2007). By the time it becomes obvious that a drug is ineffective the 
majority of the GIN population are resistant. At this point, a new drug is needed to 
manage infections.  
AR has been the impetus for the development of new drugs with different modes of 
action, but this is a slow process that cannot keep pace with the development of AR. In 
the United Kingdom and New Zealand, six drug groups are licenced for use in sheep, and 
two of these drug groups were introduced there in the past four years  (Abbott et al. 2012) 
(Table A2). But the first cases of resistance to one of these new groups, the amino-
acetonitrile derivatives, have already been reported in New Zealand (Scott et al. 2013), 
and in the Netherlands (Van den Brom et al. 2015). Only one anthelmintic, ivermectin, is 
licenced for use in sheep in Canada (University of Guelph 2012). It is unlikely that new 
anthelmintics will be introduced to Canada in the near future because the sheep industry 
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is small and therefore not highly profitable. Sheep are considered a minor species, with 
about 12 000 breeding ewes in Nova Scotia and about 1 000 000 sheep in all of Canada 
(Jones, personal communication 2014). In Atlantic Canada, off label use of 
benzimidazoles is common, and there is little information on AR (Jones 2013). AR is 
widespread in Ontario and Quebec, and a recent study found resistance to ivermectin, 
fenbendazole, and levamisole on 97%, 95%, and 6% of farms tested, respectively (Falzon 
et al. 2013b). In Ontario, fenbendazole resistance of H. contortus was found on all 11 
farms tested (Barrere et al. 2013). 
Fecal egg count reduction tests (FECRTs) are the most popular and practical method 
for identifying AR (Coles et al. 1992). Through FECRTs, resistance can be identified 
before it is obvious and while the drug is still effective enough to be useful. This test 
involves collecting fecal samples from sheep before and after treatment and calculating 
the percent reduction in mean FEC (Ministry of Agriculture, Fisheries and Food [MAFF] 
1986). When a drug is highly effective, treatment reduces mean FEC by 95%, and the 
lower limit of the 95% confidence interval is 90%. Resistance is confirmed if both 
criteria are not met, and if one criterion is not met resistance is suspected (Falzon et al. 
2014b). Larval cultures can be used in conjunction with FECRTs to identify the genera or 
species that are resistant, but this procedure is time consuming and technically demanding 
(Roeber and Kahn 2014). Abbott et al. (2012) recommend that FECRTs be conducted 
every two to three years, but, as with FEC monitoring, most farmers consider the cost of 
testing prohibitive (Jones, personal communication 2014). A FECRT potentially costs as 
much as $865 through a veterinarian (Barrere et al. 2013). The reluctance to invest in 
FECRTs is short-sighted and expensive, for AR has been estimated to cost 10-15% of the 
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carcass value, which far exceeds the cost of routine testing (Sutherland et al. 2010; Miller 
et al. 2012).   
As long as anthelmintics are in use AR cannot be prevented, but, through 
implementing sustainable integrated parasite management practices, the development of 
AR can be slowed and the useful lifetime of a drug can be maximized. With regard to 
anthelmintic treatment these practices include: using anthelmintics appropriately, 
monitoring and treating animals selectively, following quarantine protocols for animals 
that are new to the farm, and investigating treatment failure (University of Guelph 2012). 
Non-drug management practices are an important component of sustainable integrated 
parasite management. These practices reduce the need for anthelmintic treatment and 
include: pasture rotation, grazing sheep grouped by age, nutritional supplementation, and 
providing bioactive forages (Abbott et al. 2012).  
Pasture rotation involves grazing sheep on a pasture for a short period of time 
followed by a move to another pasture. In this way, pasture contamination can be kept to 
low levels. Thus, sheep face a slower rate of larval challenge and have lower infection 
levels. Ideally, sheep do not return to previously grazed pasture in the same season 
because L3s can survive for several months on pasture in warm and moist conditions 
(University of Guelph 2012). H. contortus comes only from ewes, so grazing lambs 
separately from ewes can limit infections with this species (Abbott et al. 2012). 
Nutritional supplementation with by-pass protein such as soy meal can enhance the 
immunity of adult sheep (Houdijk 2012), and bioactive forages grown on pasture such as 
chicory and sulla have anthelmintic properties (Ramírez-Restrepo and Barry 2005).  
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Maintaining adequate refugia has been recognized as one of the most important 
factors in slowing the development of AR (Barnes et al. 1995; Besier 2012; Leathwick et 
al. 2012; Leathwick and Besier 2014). Refugium refers to the portion of the GIN 
population that has not recently been exposed to a drug. This includes GIN in untreated 
sheep as well as those on pasture (Kenyon et al. 2009). Susceptible genotypes in refugia 
act to dilute resistant genotypes that survive treatment. Refugia can be maintained by not 
treating whole flocks, especially in the fall and in the winter at lambing. Treatment of 
sheep in the fall after they have been taken off pasture selects for AR because susceptible 
GIN are killed, but sheep can no longer pick up susceptible L3s (Leathwick and Besier 
2014; Falzon et al. 2013c). Treatment of ewes around lambing further selects for AR, for 
only resistant GIN remain to contaminate pastures at turn-out (Leathwick et al. 2006). 
Since H. contortus overwinters only in sheep in cold winter climates, fall and winter 
treatments can rapidly eliminate the susceptible population. Thus, with regard to H. 
contortus, whole flock treatments in the fall and at lambing are probably the biggest 
contributors to the development of AR (Le Jambre et al. 1999). 
To date, there is limited data on management practices on sheep farms in Canada 
(Falzon et al. 2013c), and only anecdotal evidence for the Atlantic Provinces. Falzon et 
al. (2013c) determined that in Ontario, mean treatment frequency was 2.6 times per year, 
and treatment was usually administered to the whole flock, on a set schedule, in addition 
to being based on symptoms. Contrary to current recommendations to treat incoming 
sheep with two anthelmintic groups (Abbott et al. 2012; University of Guelph), no drug, 
or only one drug group, was used on quarantined sheep. Furthermore, almost half of the 
farms treated all sheep around the time they were taken off pasture in the fall, and around 
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lambing. Thus, not only is AR widespread in Ontario, current farming practices favor the 
development and acceleration of AR. 
 Anecdotal evidence from Atlantic Canada is consistent with the findings in Ontario. 
In Nova Scotia in 2012 and 2013, many farms reported lamb and sheep deaths due to 
GIN, and some farms have resorted to raising animals indoors to circumvent 
unmanageable GIN infections (Jones 2013). Treating whole flocks in the fall, and all 
ewes at lambing in the winter, is common (Jones, personal communication 2014). Over 
the past three summers (2012-2014), our research group has identified H. contortus as the 
most problematic GIN species in Nova Scotia. On the basis of these findings, closantel, a 
narrow spectrum drug that targets H. contortus, has been approved for veterinary access 
through the Emergency Drug Release process. AR of GIN, in particular H. contortus, 
poses a serious threat to the sustainability of sheep production in Nova Scotia. Hence, it is 
essential to determine the efficacy of available anthelmintics in order to extend the use of 
these drugs for as long as possible and to emphasise the need for alternative non-drug 
management options (sustainable integrated parasite management). The main objectives 
of this study are to document AR and to identify the genera of infective larvae that 
survive anthelmintic treatment. Additionally, the utility of administering closantel alone 
or in combination with a drug to which H. contortus is resistant, and a non-drug 






Materials and Methods 
This study was part of a larger project, involving collaboration between Saint 
Mary’s University and the Dalhousie Agricultural College, which examined the 
epidemiology of H. contortus (Jones 2013), and options for integrated parasite 
management on sheep farms in Nova Scotia. The research team at Saint Mary’s 
University: Kathleen Hipwell, Rebecca Betts, Danielle Thibault, Natasha Osborne, Tanya 
Lawlor, and Julie Poirier, analyzed approximately 2450 fecal samples in 2013, and 2540 
samples in 2014. Overall, analysis of about half of the samples, and approximately 75% 
of the FECRT samples, as well as all larval identification, was performed by Kathleen 
Hipwell. All researchers were trained to perform FEC. Their technique was verified 
through the acceptable variation in counts among multiple (~15) subsamples from a 
single fecal solution (Torgerson et al. 2012), and consistency of FEC of the same 
McMaster slide was confirmed among researchers. 
2.1 a. Sentinel farm characteristics and FEC monitoring 
This study was conducted in Nova Scotia, Canada, with one farm contribution 
from Prince Edward Island, over two consecutive grazing seasons (May to November 
2013 and 2014). Nant y Mor farm (Farm 1), in Noel Shore, Nova Scotia (45°18'47" N, 
63°37'55" W) acted as the sentinel farm for the duration of the study (Figure 1). Nant y 
Mor has well-kept records for the past 20 years, and pasture management and 
anthelmintic treatment of sheep has remained consistent since 1997. The Nant y Mor 
flock consists of approximately 100 purebred Clun Forest sheep from five genetic lines, 
as well as a few crossbreds. New sheep are rarely added to the flock, and incoming 
16 
 
animals are quarantined according to the protocol of Abbott et al. (2012), to prevent the 
introduction of AR to the farm. From May to November 2013-2014, Nant-y-Mor 
provided fecal samples from at least 15 lambs, on approximately a bi-weekly basis, and 
the arithmetic mean FECSE was used to monitor GIN infection levels in the lamb flock. 
Prevalence (percentage of lambs infected), intensity (arithmetic mean FEC of infected 
lambs), and range (minimum and maximum FEC) were also calculated for each group of 
fecal samples. N. battus FEC were recorded for interest. 
2.1 b.FEC monitoring of peri-parturient ewes 
From late April to early July in 2013, and from late April to early June in 2014, 
Nant y Mor provided fecal samples from peri-parturient ewes to give an indication of 
peri-parturient egg shedding.  In 2013 and 2014, four and five other farms, respectively, 
submitted ewe samples at or around lambing (April-June). Most farms provided one 
batch of samples. Arithemetic mean FECSE, prevalence (percentage of ewes infected), 
intensity (arithmetic mean FEC of infected ewes), and range (minimum and maximum 
FEC) were calculated for each group of fecal samples.  
2.2 Farm selection and anthelmintics used in FECRTs 
Based on their willingness to participate, sheep producers for FECRTs were 
recruited by the project leader, Dr. Gwyneth Jones. All farms were located around 45-46 
N, 63° W (Fig. 2). To be included in the study, farms had to have at least 20 sheep (lambs 
or sheep up to three years old) that were raised on pasture. FECRTs were conducted on 
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nine farms in 2013 (Farms 1-9, Table 1) and eight farms in 2014 (Farms 1, 3, 5, 6, and 
10-13, Table 2).  
 
Figure 2. FECRT sites in Nova Scotia and Prince Edward Island.   = location of Nat-y-
Mor Farm,        = two farms,        = one farm. (Image modified from: 
http://www.wtcchalifax.com/site-tcl/media/wtcchalifax/Nova%20Scotia%20Map.jpg)  
Anthelmintic dosages were as per the manufacturer’s instructions or the 
recommended dose of levamisole (University of Guelph 2012), and were as follows: 
0.2mg/kg ivermectin (Ivomec Drench for Sheep, Merial Canada Incorporated); 








Suspension 10%, Intervet Canada Limited; Panacur, Intervet Canada Limited); 5mg/kg 
albendazole (Valbazen, Pfizer Animal Health); 10mg/kg closantel (Flukiver, Jansen 
Animal Health); and 7.5mg/kg levamisole (Chiron Compounding Pharmacy 
Incorporated). Dosages were calculated based on individual sheep weight on Farms 1, 2, 
4, 5, and 8-13, and by estimating the weight of the heaviest sheep on Farms 3, 6, and 7.  
All treatments were administered by drench (deposited into the rumen), with a 
recently calibrated drench gun. On Farms 1, 2, 4-6, and 10-13, anthelmintics were 
administered by Dr. E. Semple, Dr. G. Jones, or D. Thibault. Farms 3 and 7-9 treated 
their own sheep. Five anthelmintics were tested in the Nant y Mor flock. Most producers 
tested one or two anthelmintic(s), using their choice of treatment (Tables 1 and 2). Due to 
flock size constraints or concerns about severe parasitism, Farms 5-7, 9-11, and 13 did 
not use a control group.  
Table 1. Farm identification and anthelmintic(s) tested with FECRT in 2013. 
Farm  Drug(s) tested Dosage calculated by Control group  
1  Closantel, levamisole, 
albendazole, ivermectin 
Individual weight + 
2  Closantel, levamisole,  
ivermectin  
Individual weight + 
3  Levamisole, ivermectin Estimating heaviest weight + 
4  Levamisole Individual weight + 
5  Levamisole, albendazole Individual weight - 
6  Albendazole, pyrantel  Estimating heaviest weight - 
7  Ivermectin Estimating heaviest weight - 
8  Albendazole, ivermectin Individual weight + 





Table 2. Farm identification and anthelmintic(s) tested with FECRT in 2014. 
Farm  Drug(s) tested Dosage calculated by Control group  
1 1st: Closantel, levamisole, 
ivermectin  




Individual weight + 
 
 
3  Closantel, levamisole, 
albendazole, ivermectin 
Estimating heaviest weight + 
5  Closantel, levamisole Individual weight - 
6  Levamisole, albendazole Estimating heaviest weight + 
10  Fenbendazole Individual weight - 
11 Levamisole  Individual weight - 
12 Levamisole, albendazole Individual weight + 
13 Closantel Individual weight - 
 
2.3 FECRTs and FEC 
 With the exception of Farms 2, 3, and 11, lambs were used in FECRTs, as 
recommended by Coles et al. (1992). Sheep were randomly assigned to treatment or 
control groups, and where possible at least n=10 per group were used. To identify which 
group that sheep belonged to they were marked with livestock marker on their head, 
neck, back, or rump. Fecal samples were collected at the time of treatment, 7-10 days 
post-treatment for levamisole, and 14 days post-treatment for all other anthelmintics 
(Coles et al. 2006). One month post-treatment samples were collected for the closantel, 
levamisole, and control groups on Farm 1. The majority of samples were collected by Dr. 
G. Jones and D. Thibault. Farms 4 and 6-8 collected their own samples. Feces were 
collected rectally or off the ground in disposable gloves, and the gloves were labeled with 
ear tag numbers to identify the sheep. Following collection, samples were kept at ~4C in 
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coolers with ice packs and transported to Saint Mary’s University, in Halifax, Nova 
Scotia, where they were refrigerated at 4C until analysis. As recommended by McKenna 
(1998), samples for culture were refrigerated for less than 24 hours. 
FEC were conducted at the Department of Biology, Saint Mary’s University. 
Most samples were analyzed within two weeks of collection, but due to a backlog of 
samples in 2013, some were stored for up to three weeks. Individual FEC were 
determined using a modified McMaster technique, with a detection limit of 50epg 
(MAFF 1986; Coles et al. 1992). A saturated sodium chloride floatation solution 
(400g/L), with a specific gravity of 1.18-1.20 (Gibbons et al. 2012) was used. Three 
grams of feces (0.1g) were weighed (Ohaus Scout® Pro SP202, USA) and suspended in 
45mL of floatation solution. Smaller samples, weighing at least 1.0g, were suspended in 
an appropriate volume of solution (volume = weight x 15). The suspension was passed 
through a tea-strainer to remove large pieces of debris.  
After thoroughly stirring the filtered suspension, two sub-samples were quickly 
transferred by pipette to the two chambers of a McMaster counting slide (Chalex 
Corporation, USA) (Fig. B1). Slides were left for at least five minutes before counting, to 
allow eggs to float to the top of the chambers, and GIN eggs within the grids etched on 
the McMaster slide were observed with a compound microscope (Nikon Eclipse E200, 
Japan), at 100x magnification (Fig. B2). Eggs within both grids were counted, and the 
sum was multiplied by 50 to give the epg. The eggs of most species of strongyloidea and 
trichostrongyloidea look very similar, so they were collectively counted as GIN eggs 
(Fig. B3). N. battus eggs were counted separately, as they could be differentiated. Since 
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there is no AR in N. battus, their eggs acted as a control because if N. battus eggs were 
present after treatment, treatment failure may not have been due to AR.  N. fillicolis, S. 
papillosus, and T. ovis eggs were not counted. Photographs of GIN eggs commonly found 
in sheep feces, and the table used to record FEC, are presented in Appendix B (Fig. B4-9, 
Table B1). 
2.4 L3 culture and identification 
 Post-treatment fecal samples were cultured to identify the genera or species of 
L3s that survived anthelmintic treatment. In 2013, larval cultures were performed for 
Farms 1, 2, and 6. In 2014, larval cultures were performed for Farm 1. Individual fecal 
samples were cultured in their collection gloves, at room temperature, for at least 14 days. 
Larval identification was performed on most fecal cultures within 4 weeks, but one 
culture was seven weeks old. Cultured samples were pooled by treatment group, and L3s 
were collected using the Baermann technique (Gibbons et al. 2012). With an inverted 
microscope (Olympus Tokyo CK, Japan), the presence of L3s was determined by 
scanning a Petri dish containing a few mL of water drained from the Baermann funnel. A 
drop of this liquid was pipetted onto a microscope slide, and L3s were killed and stained 
with a drop of Lugol’s iodine. The first 100 L3s were identified, and if there were few 
larvae at least 50 slides were examined to find as many L3s as possible.  
L3s were identified at 400x magnification, with a compound microscope set on 
Ph2 (Nikon Eclipse E200, Japan). Morphological identification of L3s was based 
primarily on head-shape and tail-sheath-length by comparison with two keys (van Wyk et 
al. 2004; Gibbons et al. 2012). Gut cell shape and number were recorded when they were 
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visible. Using a calibrated ocular micrometer, sheath-length was measured to one decimal 
place using an ‘X’-system, where each large division of the micrometer equalled 1X 
(25m) (van Wyk et al. 2004). Due to the overlapping sheath-lengths of several species, 
L3s were categorized based on lengths of: 2.0X, 2.0-4.0X, 4.1-7.5X, 7.5X , and for the 
last two categories, filament length (solid section of sheath) was also measured (Table 3). 
For each treatment and/or control group, data were expressed as the percent and number 
of L3s in each category. To document the genera and species identified, photographs of 
L3s were taken with an Infinitylite camera (Lumenera Corporation, Canada) mounted 
on an Olympus CX41 compound microscope (Olympus Corporation, Japan). 
Photographs of L3 morphological characteristics, and the table used to record L3 data, are 
presented in Appendix B (Fig. B10-13, Table B2). 
Table 3. Classification system used to identify genera or species of GIN, based on L3 

















































2.5 Statistical analysis 
Data were entered into Excel spreadsheets, and Microsoft Office Excel 2010 
was used to calculate FECRs. As yet, there is no standardized method for calculating 
FECRs, and the various methods give inconsistent results (Calvete and Uriarte 2013; 
Falzon et al. 2014b). For this reason, several common formulae were used and the results 
were compared. The criterion for resistance was a 95% reduction in FEC. Percent 
efficacies were rounded to the nearest percent, but in the case of efficacies falling 
between 99.5% and 99.9%, efficacies were rounded down. Anthelmintic efficacy based 
on arithmetic group mean FEC was calculated with four formulae: 
 FECRT1 = 100 x (1 – T2/C2) (Coles et al. 1992)  
 FECRT2 = 100 x (1 – T2/C1) (McKenna 2006)  
 FECRT3 = 100 x (1 – T2/T1) (Kochapakee et al. 1995)   
 FECRT4 = 100 x (1 - T2/T1 x C1/C2) (Dash et al. 1988)   
Where:  
 T1 = pre-treatment mean of the treatment group  
 T2 = post-treatment mean of the treatment group  
 C1 = pre-treatment mean of the control group  
 C2 = post-treatment mean of the control group 
Anthelmintic efficacy based on individual FEC was calculated with two formulae: 
 iFECRT3 = (1/n)  (100 x (1 – Ti2/Ti1)) (Cabaret and Berrag 2004) – 
individually based equivalent of  FECR3 
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 iFECRT4 = (1/n)  (100 x (1 – Ti2/Ti1 x Cj1/Cj2)) (Caberet and Berrag 2004) - 
individually based equivalent  of  FECR4 
Where: 
 Ti1 = pre-treatment FEC of individual i from n hosts in the treatment group 
 Ti2= post-treatment FEC of individual i from n hosts in the treatment group 
 Cj1 = pre-treatment FEC of individual j from n hosts in the control group 
 Cj2 = post-treatment FEC of individual j from n hosts in the control group 
2.6 Grazing management to reduce treatment frequency   
At the Dalhousie Agricultural College in Bible Hill, Nova Scotia, a grazing 
management strategy to limit infections with H. contortus was investigated with the 
campus sheep flock (Farm 8). Over the grazing season of 2014, 10 lambs were grazed 
with 10 ewes, and 25 lambs were grazed without ewes. Ewes had lambed in mid-March 
and lambs were weaned before turnout on June 1 (Hines, personal communication 2014). 
On an approximately bi-weekly basis, the Dalhousie Agricultural College provided lamb 
and ewe samples from the lambs with ewes group, and lamb samples from the only lambs 
group. Arithmetic mean FECSE was used to monitor GIN infection levels in the ewes 
and each group of lambs. Prevelance (percent of and lambs or ewes infected), intensity 
(arithmetic mean FEC of infected lambs or ewes), and range (minimum and maximum 
FEC of lambs or ewes) were also calculated for each group of fecal samples. To identify 
the genera or species of L3s contributing to GIN infections in the only lambs group, a 




Data are expressed as arithmetic mean FEC in eggs per gram feces (epg). Range 
of FEC and the number of sheep sampled are given in parenthesis (range, n), and 
prevalence is given as a percentage. FEC from treated and untreated sheep were 
combined for FEC monitoring (3.1a-d). 
3.1 a. Sentinel farm FEC monitoring  
Figure 3 shows a comparison of the peak of infections to the end of the grazing 
seasons in 2012-2014 with previous work conducted in 1997 (Maal-Bared 1998). There 
has been a drastic increase in mean FEC of lambs, and this increase has been consistent 
for the last three years 2012-2014.  Also the peaks in infections came earlier and lasted 
longer than in 1997. 
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 Figure 3. Seasonal patterns of GIN infections in the lamb flock on Farm 1, over the 
grazing seasons of 1997 and 2012-2014. 
The seasonal patterns of GIN FEC in lambs throughout the grazing seasons, over 
the course of the study, are presented in Figure 4. Due to lack of feed, lambs were turned 
out on April 30 in 2013 and GIN eggs first appeared in the feces of one lamb on May 20 
(0-100, n=9) (Fig. 4). FEC remained low in June, but prevalence increased to 56%. Mean 
FEC increased rapidly in July, exceeding 1000epg (0-7000, n=26) by July 4, and reaching 
almost 5000epg (0-31 700, n=31) by July 24. At that time, nine lambs had FEC over 
5000epg, and another nine lambs had FEC over 10 000epg. Prevalence reached a 
seasonal maximum of 98% on July 10. Part of the flock was treated with anthelmintics on 






















































































































treatment at least once over the grazing season. Other than FECRT treatments, only 
lambs with high FEC were given additional treatment. Mean FEC declined from mid to 
late August (0-14 750, n=20) and rose again in September (0-17 350, n=18). Mean FEC 
decreased in October (0-16 600, n=32) in response to treatment with closantel, but 
remained high until the end of the sampling period. From July until the end of the 
sampling period, prevalence ranged from 75% to 97%, with short term decreases 
following anthelmintic treatment. Intensity of infections never exceeded mean FEC by 
more than 2000epg.  
Mean FEC followed a similar pattern in 2014, but FEC were lower than in 2013 
(Fig. 4). Lambs were turned out on May 12, and GIN eggs first appeared in the feces of 
seven lambs on June 5 (0-50, n=37). FEC remained low in June, but prevalence increased 
to 46%. Mean FEC increased rapidly in July, reaching almost 1900epg (25-26 500, n=53) 
by July 21, and almost 4500epg (700-12 050, n=9) by July 31. Prevalence reached 100% 
on July 21, and at this time three lambs had FEC over 5000epg. Part of the flock was 
treated with anthelmintics on July 21, August 2, August 18, and September 20, as part of 
FECRTs. Other than FECRT treatmens, only lambs with high FEC were given additional 
treatment, and four lambs were never treated. Mean FEC decreased from July 31 (700-  
12 050, n=9) to August 18 (0-9150, n=60), but increased again until September 20 (0-
8300, n=22). Mean FEC decreased in October (0-5200, 25), but remained high until the 
end of the sampling period. From July 31 until the end of the sampling period, prevalence 
ranged from 82% to 100%. Intensity of infections never exceeded mean FEC by more 
than 600epg. In both years of the study (2013-2014) FEC from the whole lamb flock 
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were included, not just lambs that acted as controls in FECRTs. Had only control lambs 
been used, none of the FEC would have been 0epg past mid-July. 
Figure 4. Patterns of GIN infection in the lamb flock on Farm 1, over the grazing seasons 




































































































































































3.1b. Sentinel farm FEC monitoring of N. battus 
The seasonal patterns of N.battus FEC are presented in Figure 5. In 2013, N. 
battus eggs first appeared in the feces of lambs on May 20. By May 28, 38% of sampled 
lambs were infected (0-100, n=13). Mean FEC increased until July 17 (0-250, n=31), 
decreased steadily to a low of 5 on August 7 (0-200, n=47), and then rose again until the 
end of the sampling period. From June 2 to July 10, prevalence ranged from 62% to 88%. 
Following anthelmintic treatment on July 10, as part of a FECRT, prevalence fell sharply 
to 29% on July 17 (0-250, n=37). Prevalence remained below 22% until the end of the 
sampling period. Intensity of infections never exceeded mean FEC by more than 209epg  
More variability was observed in mean FEC in 2014, but counts were generally 
higher than in 2013 (Fig. 5). N. battus eggs first appeared in the feces of lambs on May 
30. Mean FEC rose until June 22 (0-550, n=26), when prevalence reached a maximum of 
96%. Following anthelmintic treatment on July 21, as part of a FECRT, prevalence 
decreased to 40% on August 18 (0-550, n=60). Prevalence remained below 45% until the 
end of the sampling period. Intensity of infections never exceeded mean FEC by more 
than 162epg. Throughout 2013 and 2014 no lambs required treatment to manage N. 
battus infections. The prevalence of N. battus two weeks post-treatment was due to the 




Figure 5. Patterns of N. battus infection in the lamb flock on Farm 1, over the grazing 
seasons of 2013 and 2014. 
3.1c. Sentinel farm FEC monitoring of peri-parturient ewes 
Figure 6 represents two groups of peri-parturient ewes. The first three samplings 
were from the late lambing group (late April to early May) before and around lambing 
(pattern filled columns). All subsequent samplings were from the early lambing group 
(late February to early March) during late lactation. On Farm 1 in 2013, mean FEC of 
ewes was low in late April (0-2700, n=8) and early May (0-2650, n=14) (Fig. 6). Mean 
FEC rose rapidly in mid-May (50-34 250, n=14) and remained high until mid-June (400-
11 550, n=8). Prevalence was 100% during this period. By early July prevalence had 
decreased to 70%, and with the exception of three ewes, with FEC of 12 950, 17 875, and 

































































































































































Figure 6. Pattern of GIN infection in ewes on Farm 1, around lambing and lactation in 
2013.  
Figure 7 represents two groups of peri-parturient ewes. The first sampling was 
from the early lambing group (late February to early March) during late lactation (pattern 
filled column). All subsequent samplings were from the late lambing group (late April to 
early May) before and around lambing. On Farm 1 in 2014, mean FEC of ewes was high 
when sampling began in late April (100-9700, n=16), and remained high until June 5 
(100-11 400, n=7) (Fig. 7). At each sampling, at least three ewes had counts above 


























Figure 7. Pattern of GIN infection in ewes on Farm 1, around lambing and lactation in 
2014. 
3.1d. FEC monitoring of peri-parturient ewes  
In May 2013, mean FEC of ewes on Farms 2 and 3 were 1021epg (150-2650, 
n=12) and 1682epg (0-6000, n=14), respectively. On Farm 3, two ewes had counts over 
5000epg. In June, ewes from Farms 3, 5, and 7 had mean FEC of 954epg (0-4950, n=14), 
4396epg (100-22 000, n=12), and 972epg (0-2550, n=9), respectively. Three ewes on 
Farm 5 had FEC over 5000epg.  
On Farm 3 in 2014, from May 20 to May 29, mean FEC in ewes increased from 
1169epg (0-5000, n=76) to 1588epg (0-14 050, n=64). Most ewes in this flock were 
























June 3. Around mid-June, mean FEC on Farms 2, 3, 8, 10, and 12 ranged from 1509epg 
to 5441epg. On each farm at least one ewe had a FEC over 11 000epg. 
3.2 FECRTs  
The results of the FECRTs in 2013 are shown in Table 4. Resistance to 
albendazole was found on 3/4 farms. Depending on the formulae used, resistance to 
ivermectin was found on 6/7 or 7/7 farms. On Farm 1, a double dose of ivermectin 
improved efficacy, but the status remained resistant. Depending on the formulae used, 
resistance to levamisole was found on 3/5 or 1/5 farms. Typically, the resistant status 
resulted from one levamisole treated lamb with a high FEC post-treatment, which may 
reflect poor dosing technique. Pyrantel also showed resistance or susceptibility. Apparent 
resistance to closantel was found on 2/2 farms tested, but the resistant status is misleading 
because closantel kills only H. contortus. 
The results of the FECRTs in 2014 are shown in Table 5. Resistance to 
albendazole was found on 4/4 farms tested. A re-test of ivermectin on Farm 3 showed 
resistance, and all of the percentage reductions were negative. Moxidectin, which is in the 
same drug group as ivermectin, was effective on Farm 1. Depending on the formulae 
used, resistance to levamisole was found on 1/6 or 0/6 farms, and resistance to closantel 
was found on 3/4 or 4/4 farms. As in 2013, the apparent resistant status of closantel is 
misleading because closantel kills only H. contortus. For each of the six formulae, 
percent reductions for closantel on Farm 1 were higher in the first trial, in July, compared 
to the second trial, in October. GIN were susceptible to the closantel and albendazole 
combination on Farm 1. 
34 
 
Table 4. Fecal egg count reduction percent and AR status for nine farms in 2013, 
calculated using six formulae. GIN were classified as resistant (R) when treatment 
reduced mean FEC by <95% and susceptible (S) when treatment reduced mean FEC by 
95%.  
                           
A dash indicates that FECRT calculations were not possible due to the lack of a control 
group, or an insufficient number of pre- and post-treatment samples from the same 
animals for iFECRT3. 
Anthelmintic Farm
albendazole 1 71 R -311 R -73 R -177 R 12 R 43 R
5  -  -  -  - -15 R  -  -  -  -  -  -
6  - -  -  - 63 R 65 R  -  -  -  -
8 100 S 100 S 100 S 100 S 100 S 100 S
ivermectin 1 5 R -1222 R -488 R -391 R -57 R -1 R
2 31 R -15 R -49 R 11 R -56 R 38 R
3 48 R -20 R -39 R -149 R 60 R -105 R
7  -  -  -  - 77 R 75 R  -  -  -  -
8 -46 R 11 R 97 S 95 S 99 S 98 S
9  -  -  -  - 37 R 26 R  -  -  -  - 
2X ivermectin 1 10 R 29 R 77 R 77 R 71 R 81 R
levamisole 1 99 S 99 S 99 S 98 S 99 S 99 S 
2 95 S 89 R 92 R 96 S 97 S 97 S
3 88 R 81 R 84 R 99 S 91 R 98 S
4 99 S 99 S 99 S 99 S 99 S 98 S
5  -  -  -  - 79 R  -  -  -  -  -  -
pyrantel 6  -  -  -  - 97 S 90 R  -  -  -  -
closantel 1 68 R 70 R 72 R 69 R 64 R 22 R
2 86 R 90 R 92 R 90 R 89 R 89 R
FECRT1 FECRT2 FECRT3 iFECRT3 FECRT4 i FECRT4
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Table 5. Fecal egg count reduction percent and AR status for eight farms in 2014, 
calculated using six formulae. GIN were classified as resistant (R) when treatment 
reduced mean FEC by <95% and susceptible (S) when treatment reduced mean FEC by 
95%.
        
A dash indicates that FECRT calculations were not possible due to the lack of a control 
group, or an insufficient number of pre- and post-treatment samples from the same 
Anthelmintic Farm
albendazole 1 66 R 43 R 73 R 78 R 84 R 76 R
1  -  -  -  - 71 R 97 S  -  -  -  - 
3 47 R 34 R 12 R -98 R 29 R -48 R
6 -160 R -941 R -95 R -374 R 52 R -353 R
12 -8 R 68 R 78 R 80 R 82 R 82 R
fenbendazole 10  -  -  -  - 55 R 25 R  -  -  -  - 
ivermectin 3 -196 R -266 R -438 R -388 R -334 R -599 R
moxidectin 1 98 S 92 R 98 S 98 S 99 S 98 S
levamisole 1 99 S 98 S 97 S 99 S 99 S 99 S
3  -  -  -  - 99 S 97 S  -  -  -  - 
5  -  -  -  - 99 S 99 S  -  -  -  - 
6 100 S 100 S 100 S 100 S 100 S 100 S
11  -  -  -  - 97 S 73 R  -  -  -  - 
12 95 S 99 S 99 S  -  - 98 S  -  - 
closantel 1 90 R 68 R 92 R 82 R 97 S 94 R
1 66 R 42 R 87 R 71 R 84 R 68 R
3 88 R 85 R 62 R 16 R 69 R -3 R
5  -  -  -  - 75 R 65 R  -  -  -  - 
13  -  -  -  - 64 R  -  -  -  -  -  - 
closantel + albendazole 1  -  -  -  - 98 S 95 S  -  -  -  - 




animals for iFECRT3 and iFECRT4. *Efficacy was 100% except in one lamb for the 
closantel + albendazole group. 
 There was overlap in the farms tested in 2013 and 2014. Some farms tested a 
different anthelmintic(s) in 2014, and others retested an anthelmintic in addition to 
another drug(s). In total, FECRTs were performed on 13 farms and most tested one or 
two anthelmintics. A summary of the FECRT results over the two years of the study is 
presented in Figure 8. For farms that used a control group, the AR status was defined 
according to iFECRT4, except for Farm 12 where FECRT4 was used due to an 
insufficient number of pre- and post-treatment samples from the same animals. For farms 
that did not use a control group the AR status was defined according to iFECRT3, or 
FECRT3 if there was an insufficient number of pre- and post-treatment samples from the 
same animals. The susceptibility of GIN to albendazole and ivermectin occurred on only 
Farm 8. All other farms that tested these anthelmintics had resistance to either or both 
drug(s). Retesting of levamisole showed that GIN were susceptible on all eight farms. For 
anthelmintics other than closantel it was noted that N. battus FEC were 0epg in post-
treatment groups, except for a single lamb in three groups and two lambs in one group. In 




Figure 8. Summary of the resistance status of GIN on the 13 farms tested with FECRTs 
over the course of the study (2013-2014).            Apparent resistant status of closantel is 
misleading, as it kills only H. contortus.  
3.3 L3 culture and identification 
Larvae were allocated to a species group based on tail-sheath-length and head 
shape, and classified as: short with square head (Teladorsagia 
circumcincta/Trichostrongylus spp.), medium with round head (Haemonchus 
contortus/Cooperia spp.), or long with a broad square or broad round head (Chabertia 
ovina/Oesophagostomum spp./Bunostomum spp.). Gut cell shape and number were used 





























In 2013, a pre-treatment larval culture from Farm 1 contained over 90% 
Haemonchus contortus/Cooperia spp.. Two weeks post-treatment larval cultures for 
ivermectin on Farms 1 and 2, and for albendazole on Farm 6 contained only Haemonchus 
contortus/Cooperia spp.. In 2014, two weeks post-treatment larval cultures and FEC from 
Farm 1 showed that only Haemonchus contortus/Cooperia spp. survived treatment with 
moxidectin, but moxidectin was effective at reducing FEC to well below pathogenic 
levels (Fig. 9). Haemonchus contortus/Cooperia spp. was the dominant species in the 
control culture. Few larvae were recovered from the albendazole culture. The culture of 
closantel had a smaller proportion of Haemonchus contortus/Cooperia spp., relative to 
the control, moxidectin, and albendazole cultures. Only one FEC was not 0epg in lambs 
treated with the closantel and albendazole combination. Thus, no larvae could be 
recovered from the other lambs in the treatment group. Levamisole was so effective in 
reducing FEC that no larvae were recovered from the culture. When anthelmintics are 




Figure 9. Percent (top) and number (bottom) of infective larvae per species group 
recovered from fecal cultures from Farm 1 in 2014, two weeks post-treatment. Numbers 
above the columns in the top graph indicate the total number of larvae. 





































































































In 2014, one month post-treatment larval cultures from Farm 1 showed that 
levamisole treated lambs had a similar proportion of Haemonchus contortus/Cooperia 
spp. as the control group, but a greater proportion of Teladorsagia 
circumcincta/Trichostrongylus spp., and a lower proportion of Chabertia 
ovina/Bunostomum spp./Oesophagostomum spp. (Fig. 10). Also, levamisole treated 
lambs had a higher mean FEC than the control group. The proportion of Haemonchus 
contortus/Cooperia spp. was much lower in the closantel group, relative to the control 
and levamisole cultures. FEC of the closantel group were lower one month post-treatment 






 Figure 10. Percent (top) and number (bottom) of infective larvae per species group 
recovered from fecal cultures from Farm 1 in 2014, one month post-treatment. Numbers 




























































































Pre- and two weeks post-treatment larval cultures and FEC from albendazole 
treated lambs on Farm 1 in 2014 showed that Haemonchus contortus/Cooperia spp., 










Figure 11. Percent (top) and number (bottom) of infective larvae per species group 
recovered from fecal cultures from Farm 1 in 2014, pre- and two weeks post-treatment 



























































































Although only Haemonchus contortus/Cooperia spp. survived treatment with 
moxidectin, by six weeks post-treatment, lambs had become re-infected with 




Figure 12. Percent (top) and number (bottom) of infective larvae per species group 
recovered from fecal cultures from Farm 1 in 2014, pre-, two weeks, and six weeks post-






































































































number of larvae. X indicates that mean FEC was not available for the six weeks post-
treatment samples. 
3.4 Grazing management to reduce treatment frequency 
On Farm 8 in 2014, the mean FEC of ewes was high when sampling began and 
two ewes had FEC over 7000epg (0-11 500, n=10) (Fig. 13). FEC dropped rapidly in 
July. Prevalence in ewes decreased over the grazing season, from 100% on July 8 to 20% 
on August 26 (0-600, n=10). In the group of only lambs, mean FEC remained low and 
lambs went untreated. By August 26, only two lambs had FEC over 1500epg (0-1800, 
n=16). Lambs grazed with ewes required anthelmintic treatment on August 12. On this 
date four lambs had FEC 2400epg, and another lamb had a FEC of 19 150epg (0-        
19 150, n=10). On August 3 and August 12, the mean FEC of lambs grazed with ewes 
was influenced by the one lamb with a very high FEC. In the only lambs group, two 
lambs consistently had higher counts than the rest of the group, from August 3 to August 
26. With the exception of July 8, prevalence in the group of only lambs was lower than in 
the group of lambs with ewes. From July 21 to August 26, prevalence in the only lambs 
group ranged from 64% to 75%. Over the same period, prevalence in the lambs with ewes 
group ranged from 88% to 100%. At the end of the grazing season, a larval culture from 
the only lambs group showed that over 30% of larvae were Haemonchus 
contortus/Cooperia spp. (Fig. 14). This composite culture contained feces from four of 
the lambs with higher counts. 
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Figure 13. Seasonal patterns of GIN infection in ewes, a group of lambs grazed with 
ewes, and a group of only lambs on Farm 8 in 2014.      No data was available for the 






















ewes lambs with ewes only lambs
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Figure 14. Percent (top) and number (bottom) of infective larvae per species group 
















































































grazing season in 2014. The number above the column in the top graph indicates the total 



















4.1 a. Sentinel farm FEC monitoring 
Over the grazing season, GIN infections in lambs come from three sources: 
overwintered larvae on pasture at turnout (Smith and Fulton 1989), larvae from eggs shed 
by peri-parturient ewes in early summer, and larvae from eggs shed by lambs as they re-
infect themselves in mid-summer to fall (Abbott et al. 2012). Sheep went out to pasture 
12 days later in 2014, which explains the later appearance of eggs in the feces. In both 
2013 and 2014, GIN eggs first appeared in the feces of lambs around three weeks after 
turnout. N. battus eggs first appeared in the feces of lambs 18 days after turnout on Farm 
2 in 2013, and 18 days after turnout on Farm 1 in 2014. This timing coincides with the 
pre-patent periods of T. circumcincta and Trichostrongylus spp. (2-3 weeks) and N. 
battus (14-16 days). Since H. contortus does not survive overwinter, this species would 
not have contributed to initial lamb infections (Troell et al. 2009; Waller et al. 2004; Groz 
et al. 2013).  
Most GIN eggs cannot be differentiated by microscopy. Yet, for species other 
than H. contortus, FEC over 1500epg indicate infections severe enough to cause 
excessive diarrhea and even death (Abbott et al. 2012). H. contortus causes anemia and 
masks diarrhea (University of Guelph 2012). Thus, in sheep with high FEC (2000epg) 
that were not scouring, H. contortus was the major contributor to infections. Ewe FEC 
were high at turnout in 2013 and 2014 and several ewes had pale conjunctiva (a sign of 
anemia), and no diarrhea (Jones, personal communication 2014). Consequently, these 
ewes were contaminating the pasture with huge numbers of H. contortus eggs from May 
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through June. For example, a ewe with 500 adult female H. contortus (a pathogenic but 
manageable worm burden) (Abbott et al. 2012) could deposit up to 5 000 000 H. 
contortus eggs per day onto pasture.  
As eggs shed by peri-parturient ewes developed to infective larvae over the 
grazing seasons, FEC rose rapidly in lambs in July as they became infected with H. 
contortus. H. contortus can take up to two months to develop to the infective stage at 
lower temperatures (20C), but as little as 5 days in hotter conditions (University of 
Guelph 2012). So, pastures can go from being highly contaminated to highly infective 
within a few weeks, as eggs laid earlier and later in the season develop to infective L3s at 
the same time. In 2013 and 2014, it took 46 and 47 days after turnout, respectively, for 
mean FEC to exceed 1000epg. Based on high FEC, pale conjunctiva indicating anemia, 
the absence of scouring, (Jones, personal communication 2014), and larval cultures, H. 
contortus was identified as the predominant species contributing to lamb infections from 
July through October. These results are consistent with those of Mederos et al. (2010), 
who identified H. contortus as the predominant species in Ontario and Quebec, from 
April through September of 2007. The inclusion of ewes in their study explains the 
dominance of H. contortus throughout the sampling period. 
T. circumcincta and Trichostrongylus spp. lay far fewer eggs per day and develop 
more slowly than H. contortus (Abbott et al. 2012), so, although T. circumcincta and 
Trichostrongylus spp. continued to contribute to infections throughout the season, it took 
longer for lambs to pick up sub-clinical or pathogenic burdens of these species. On farm 
1 in 2013 and 2014, very few lambs (5) were scouring in August, a symptom of 
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infection with T. circumcincta and Trichostrongylus spp. (Jones, personal communication 
2014). The decreases in FEC observed in late September of 2013 and 2014 were 
consistent with incoming L3s becoming hypobiotic rather than developing into adults 
(Waller et al. 2004; Groz et al. 2013), as well as the lambs’ development of acquired 
immunity to GIN (Abbott et al. 2012). 
In lambs, the lower infection levels observed in 2014 compared to 2013 were 
influenced by different weather patterns. Based on monthly soil temperature and 
precipitation averages over the grazing seasons, 2014 was hotter and drier in June than in 
2013 (Jones and Semple, personal communications 2015). Eggs, L1s, and L2s are 
particularly susceptible to desiccation (Morgan and van Dijk 2012). L3s are protected 
from desiccation by their cuticle, but they cannot feed. In tropical regions, higher 
temperatures cause L3s to use up their limited energy reserves quickly, resulting in larval 
mortality and reducing pasture infectivity. However, in temperate climates such as in 
Nova Scotia, temperatures are not high enough to kill L3s in this manner (University of 
Guelph 2012). Although pastures became highly contaminated in both years, the dry 
conditions in 2014 would have reduced pasture infectivity by killing off eggs, L1s, and 
L2s, thus leading to lower infection levels. GIN that survived to the L3 stage would have 
been little affected (Eysker et al. 2005; Reynecke et al. 2011). The use of moxidectin and 
closantel in July of 2014 were additional factors in lowering the infection levels, since 
both drugs were effective and had persistent activity. Mean FEC for closantel treated 
lambs was lower (139epg) (50-1100, n=11) one month post-treatment than two weeks 
post-treatment (397epg) (0-1300, n=11). Hence, moxidectin and closantel treated sheep 
reduced the mean FEC of the flock.  
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4.1b Sentinel farm FEC monitoring of N. battus 
N. battus eggs are easily differentiated from GIN eggs, and infections arise from 
lamb to lamb transmission, from one year’s lambs to the next year’s lambs. The typical 
pattern of infection is a rapid rise in FEC early in the grazing season, followed by a rapid 
decrease in FEC a few weeks later, as lambs develop immunity to this species (Winter 
2002). A pronounced peak in mean FEC was observed from June through July in 2013, 
and a peak followed by a more gradual decline was observed from mid-June through 
August in 2014. Minimal exposure is needed for lambs to develop a good immune 
response to N. battus (Taylor and Thomas 1986), and the declines observed in mean FEC 
support the quick development of immunity. In both years (2013-2014), mean N. battus 
FEC never exceeded levels indicating moderate infections (150-300epg), and even lambs 
with FEC over 700epg (indicating severe infections) were not scouring (Abbott et al. 
2012). These results are consistent with anecdotal evidence from other farmers who have 
not encountered problems with this species (Jones 2013). Unlike other parts of Canada 
where N. battus is not thought to be prevalent (University of Guelph 2012), 24/25 farms 
in Nova Scotia that submitted random samples in 2013 and 2014 had N. battus (Jones 
2013). Farm 7 was the only farm without N. battus, and this farm lambed in June. 
Overwintered N. battus would not have survived on pasture long enough to infect the 
lambs on Farm 7. 
In contrast to the United Kingdom where gradual and consistent increases in 
temperature in the spring result in mass hatches of N. battus, high rates of larval 
challenge, and consequently lamb mortality (National Animal Disease Information 
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Service 2014), the erratic pattern of temperature increases in the spring in Nova Scotia 
does not favor mass hatches. Accordingly, lambs in this region face a slower rate of larval 
challenge, thus reducing clinical illness. Moreover, FEC do not necessarily correlate with 
disease severity, for it is the immature stages and egg laying adults that are the source of 
illness (Abbott et al. 2012). Mean N. battus FEC were higher in 2014 than in 2013. This 
may be explained by the development of N. battus to the infective stage inside the egg. 
The dry conditions of 2014 that lowered pasture infectivity of GIN would have had a 
lesser impact on the development and survival of N. battus since its thick shelled, hardy 
egg is more desiccation resistant than those of GIN, and L1s and L2s are not exposed to 
the environment (Abbott et al. 2012).  
Throughout the grazing seasons of 2013 and 2014, N. battus counts trickled on, 
followed by increases in mean FEC at the end of the grazing seasons. This suggests that 
N. battus is completing its life cycle in the same season. In response to climate change, N. 
battus has adapted to produce a second generation in the autumn in England and Scotland 
(van Dijk and Morgan 2010). Given that L3s hatched from eggs that overwintered on 
pasture survive for only a few weeks (Morgan and van Dijk 2012), it is unlikely that late 
season infections arose from overwintered eggs. Autumn hatching is further supported by 
N. battus L3s recovered from a fecal culture from Farm 8, which was collected on August 
13 and analyzed on October 1 (Fig. B14-15).  According to van Dijk and Morgan (2010), 
a second generation of N. battus can develop to the L3 stage in about seven weeks. This 
timing, plus the 14-16 day pre-patent period, coincides with the periods between the first 
appearance of N. battus eggs in the feces and the beginning of the second increase in both 
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years, as well as the age of the fecal culture from Farm 8. Larval cultures and/or herbage 
samples could confirm autumn hatching on Farm 1.  
4.1c FEC monitoring of peri-parturient ewes 
 The high FEC of peri-parturient ewes on other farms (Farm 2, 3, 5, 7, 8, 10, and 
12) corroborate the results from Farm 1. In Nova Scotia, peri-parturient egg shedding is a 
major source of pasture contamination with H. contortus. Most farms provided samples 
during late-lactation. In Ontario, this stage is associated with the highest FEC (Falzon et 
al. 2013a). It would be useful to determine the patterns of FEC over the entire lambing 
period. A survey of peri-parturient ewes from before and around lambing on, with and 
without supplementation with soy meal, is underway on Farm 1. Soy meal provides 
additional protein, which can improve immunity (Houdijk 2012, Houdijk et al. 2012). 
Preliminary results indicate low FEC before lambing. 
4.2 FECRTs 
Typically, FECRT calculations include two criteria to classify GIN as 
anthelmintic resistant: a 95% reduction in mean FEC, and a lower limit of a 95% 
confidence interval 90%. If both criteria are met GIN are classified as resistant, but if 
one criterion is not met resistance is suspected. Otherwise, GIN are classified as 
susceptible (Coles et al. 1992). In this study, one criterion for resistance was used: a 
95% reduction in mean FEC. Many methods for calculating percent reductions can be 
found in the literature. Options include using: group mean FEC (Cole et al. 1992; 
McKenna 2006), group composite FEC (Rinaldi et al.2014), individual FEC (Caberet and 
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Berrag 2004), a general linear mixed model (Mejía et al. 2003), a negative binomial 
maximum likelihood model (Torgerson et al. 2005), and Bayesian analysis (Torgerson et 
al. 2014). Several of the above methods also have corresponding versions using 
geometric means (Presidente 1985), log transformed values and/or bias correction terms 
(Falzon et al. 2014; Torgerson et al. 2005; Dobson et al. 2012). The lack of consensus 
regarding which statistical method is best stems from the many factors that affect the 
results of FECRTs such as: FEC techniques, baseline FEC, sample size, aggregation of 
FEC, FECRT formulae, and the inclusion of a control group (Vidyashankar et al. 2012).  
Also, for field use, trade-offs among accuracy, affordability, and animal welfare are 
necessary so that farmers are willing and able to adopt routine testing. 
Efficacies in this study were either so high or so low that confidence intervals 
were unnecessary. Furthermore, methods for calculating confidence intervals were not 
user friendly, and for the six formulae used, confidence intervals are based on the 
erroneous assumption of normality of FEC (Coles et al. 1992). Log transformation of 
FEC is often employed to make data conform to a normal distribution and to eliminate 
FEC of 0epg. However, the constant added to FEC in log transformations is inconsistent, 
with some researchers adding 1 and others adding half the detection limit of the FEC 
technique (Dash 1988; da Sliva et al. 2011). This hampers the comparison of results 
across studies. Indeed, the method advocated by the W.W.A.V.P. (for FECRT1) does not 
specify the constant to be added to FEC (Coles et al. 1992), and many studies that use 
this formula do not include this information.  
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A preliminary assessment of this study’s data did not identify any groups as 
normally distributed based on the Anderson-Darling normality test, and log transforming 
FEC did not always produce normally distributed data. Confidence intervals are 
considered to be useful when resistance is emerging, because FECRTs suffer from poor 
sensitivity when efficacies fall between 90% and 95%. Additionally, for any sample size 
or level of aggregation, FECRTs cannot accurately identify resistance or susceptibility 
when true drug efficacy ranges between 87.5% and 92.5% (Levecke et al. 2012). For 
research purposes, where conditions are rigorously controlled and accuracy is important, 
confidence interval methods that incorporate the over dispersion of FEC may be 
appropriate (Cabaret and Berag 2004; Torgerson et al. 2014). However, for field use the 
biologically relevant information lies in the individual FEC and percent efficacies. These 
provide sufficient information to make treatment decisions and to quantify AR. As well, 
percent efficacies are easily understood and not intimidating to farmers.   
The detection limit of FEC techniques ranges from 1epg for the FLOTAC method 
(Cringoli et al. 2010) to 50epg for the modified McMaster method used in this study 
(MAFF 1986). Regardless of the technique, sampling errors are then exaggerated by the 
multiplication of raw egg counts by the dilution factor (Torgerson et al. 2012). Accuracy 
and precision of FEC are improved with lower detection limit techniques (Godber et al. 
2015; Bosco et al. 2014), but this improvement is marginal if baseline FEC are high 
(Levecke et al. 2011). Furthermore, FLOTAC is labour intensive, requires two 
centrifugation steps, and the counting apparatus is not commercially available (Cringoli 
et al. 2010). By contrast, the modified McMaster technique is widely used in FECRTs 
and flock monitoring for both research purposes and in the field (University of Guelph 
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2012; Abbott et al. 2012). This method requires limited training and equipment, and due 
to its practicality and affordability the McMaster technique could be taught to farmers in 
Nova Scotia. This would enable them to monitor their own sheep and avoid the high cost 
of testing by a laboratory ($6 - $20 per sample) (Jones, personal communication 2014). 
To date, our research team has trained two farmers to perform FEC. The author and other 
members of our research team have demonstrated the technique at workshops and at the 
PSBANS Annual Fall Sheep Sale for the last three years.  
FECRTs produce unreliable data when baseline FEC are low (Vidyshankar et al. 
2012). According to Falzon et al. (2013b) FECRTs require a minimum group mean 
FEC>300epg to provide reliable results, but current recommendations of the W.W.A.V.P. 
require a minimum group mean of only FEC150epg (Coles et al. 2006). These low pre-
treatment thresholds can result in some sheep having FEC of 0epg, creating zero inflated 
outcomes. Zero counts are uninformative for they may reflect a true lack of infection, 
making such sheep unsuitable for drug testing, or result from variation due to random 
sampling of the fecal filtrate (Torgerson et al. 2012).  
Yet, in this study low baseline FEC and zero inflation were not an issue. In 2013, 
with the exception of three FECRT groups with mean FEC ranging from 192-513epg, all 
groups had mean FEC over 1000epg.  Similarly in 2014, with the exception of four 
groups with mean FEC ranging from 275-685epg, all groups had mean FEC near or over 
1000epg. In fact, FEC monitoring of just the sentinel farm was sufficient to determine 
when FEC on other farms would be high enough for FECRTs. Concerning FEC of 0epg, 
in 2013, 8/26 groups of lambs had a single FEC of 0epg, and 3/26 groups had two lambs 
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with FEC of 0epg. In 2014, 1/22 groups involved in FECRTs had a single FEC of 0epg. 
A bias correction can be added to eliminate FEC of 0epg, but this can have a great effect 
on the percentage efficacy of the anthelmintic. When Falzon et al. (2014b) reanalyzed 
FECRT data using a bias correction term of 25epg (half the detection limit of the FEC 
technique) the resistant status of levamisole for one farm remained the same, but the 
percent reduction increased from 6% to 92%.  
In this study, inclusion or exclusion of lambs with FEC of 0epg did not greatly 
affect percent efficacies or change the resistance status, and these lambs could have been 
excluded from the analysis (data not shown). Lambs with pre-treatment FEC of 0epg 
were retained for consistency with current protocols and because post-treatment counts 
0epg were obtained for some treated lambs. For some of these lambs, FEC of 0epg 
likely reflected variation due to random sampling and/or the high detection limit of the 
FEC technique, rather than a lack of infection at the beginning of the FECRT.  
The impacts of over-dispersion and small sample sizes can be seen in the percent 
efficacies, and the disagreement in resistance status, for ivermectin on Farm 8. One lamb 
in the treatment group had an extremely high pre-treatment FEC of 24 500epg, and thus 
mean FEC were dissimilar between the treatment group 6010epg (0-24 500, n=5) and the 
control group 192epg (0-450, n=6). When this lamb was excluded from the analysis, 
efficacies were 100% for all six formulae. But, exclusion of lambs with high FEC is 
inappropriate, as they are not outliers in the traditional sense but are part of the typical 
pattern of parasite distribution within a population (Barger 1985). Treatment of this lamb 
reduced its FEC from 24 500epg to 850epg, a 97% reduction. Due to the single high 
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count at the beginning of the test, FECRT1 and FECRT2 failed to capture the efficacy of 
the drug, and erroneously indicated high levels of resistance (-46% and 11% efficacy, 
respectively). The other four formulae, which included pre- and post-treatment FEC from 
treated lambs, provided a more reliable assessment of drug performance and gave 
susceptible statuses with efficacies ranging from 95% to 99%.  Sample sizes on Farm 8 
were small (n=5-6), and given the over-dispersion of parasitic infections, a larger sample 
size may have resulted in a similarity of counts between the treatment and control group, 
more consistency among percentage efficacies, and agreement in resistance status across 
formulae. The recommendation of Coles et al. (1992) to include at least 10 sheep per 
group may be problematic on farms with few lambs.  
AR to the only two available drug groups in Canada, the benzimidazoles 
(albendazole and fenbendazole) and the macrocyclic lactones (ivermectin and 
moxidectin), was present and in many cases, efficacies were too low to provide adequate 
worm control. Sheep disease and even death are likely when efficacy is below 60% 
(Abbott et al. 2012). Albendazole is no longer useable on 3/6 farms tested (Farms 3, 5, 
and 6). Similarly, on 4/6 farms that tested ivermectin, (Farms 1, 2, 3, and 9) efficacies 
were so low that this drug needs to be abandoned. On the aforementioned farms, slight 
decreases in mean FEC and increases as high as 4000epg were observed post-treatment. 
AR to both albendazole and ivermectin was documented on 2/3 farms (Farms 1 and 3) 
that tested both drugs.  
Farm 8 was the only farm where GIN were susceptible to both albendazole and 
ivermectin. However, lambs on Farm 8 were grazed with fall lambed ewes (October) 
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(Hines, personal communication 2014). These ewes were several months past parturition 
and would have had immunity to GIN, and thereby shed low numbers of eggs. So, there 
would have been less contamination of pastures with H. contortus. This is supported by 
the relatively low pre-treatment mean FEC of lambs from Farm 8 compared to the other 
farms, all of which lambed in the winter and/or the spring. 
On Farm 1 the efficacy of albendazole was approximately 70% in 2014. Post-
treatment larval cultures from albendazole treated lambs yielded just eight larvae, even 
though the mean FEC was over 800epg. Such low numbers were due to the ovicidal 
properties of albendazole. Resistant survivors produce eggs, but many do not hatch 
(Abbott et al. 2012). On Farms 1, 8, and 12, albendazole may be effective enough (70%) 
to prevent production losses with frequent use. Fenbendazole is in the same drug group as 
albendazole, and high levels of resistance were identified on the one farm tested.  
Ivermectin, the only anthelmintic licenced for use in sheep in Canada, showed the 
highest levels of resistance. This is unsurprising, as it has been used extensively for years, 
and many farmers have stopped using it due to its obvious ineffectiveness (author’s 
observation). Moxidectin is a stronger but similar drug to ivermectin, and it was highly 
effective on Farm 1, where GIN were resistant to a double dose of ivermectin. 
Reportedly, moxidectin works on other farms too, and it has become a popular alternative 
to ivermectin (Jones, personal communication 2015). But, as was observed in a post-
treatment larval culture, H. contortus/Cooperia spp. survived treatment, albeit in low 
numbers. Since moxidectin and ivermectin work by a similar mechanism (Bygarski et al. 
2014; Kotze et al. 2014), and H. contortus can develop resistance rapidly, it is unlikely 
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that switching to moxidectin will provide adequate worm control for more than a few 
years. This phenomenon is called side resistance, whereby resistance to one drug confers 
resistance to other drugs in the same class. According to Bygarski et al. (2014), GIN 
resistant to ivermectin are at least partially resistant to moxidectin. Also, moxidectin is an 
injectable drug, which is licenced for use in cattle, but it is given to sheep as a drench. 
This route of administration results in a high drug concentration in the abomasum - where 
H. contortus, T. circumcincta, and one species of Trichostrongylus live - and reduces the 
period over which GIN are exposed to a sub-therapeutic concentration of the anthelmintic 
(Lanusse et al. 2014). Oral administration of injectable anthelmintics is not advised in 
Canada (University of Guelph 2012) 
GIN were susceptible to levamisole on 8/8 farms tested, and efficacies ranged 
from 96% to 100%. Where the resistance status depended on the FECRT formulae, such 
as for Farms 2 and 3 in 2013, efficacies were typically higher for the individually based 
and more complete formulae (96% to 99%). Additionally, a retest of levamisole on Farms 
3 and 5 in 2014 showed efficacies of 97% and 99%, confirming susceptibility. However, 
levamisole is not licenced in Canada and is available only from a veterinary 
compounding pharmacy. Since the vehicle for drug delivery may differ among 
pharmacies there is no withdrawal time (to enter the food chain) available for this 
anthelmintic. The high efficacies of levamisole were expected because it has not been 
commercially available for the last 10 years (Lexchin 2005), which predates the recent 
problems with H. contortus. Despite its efficacy, levamisole’s short duration of activity 
made frequent treatment necessary. On Farm 1 in 2014, one month post-treatment FEC of 
6/11 lambs were high enough to warrant re-treatment. 
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Pyrantel is similar to levamisole and is for use in horses. Very little of the drug is 
absorbed, and most is passed unchanged in the feces. Efficacy depends on the period over 
which GIN are exposed to the anthelmintic in the lumen of the horse’s digestive tract 
(Gokbulut et al. 2001). There are no dosage guidelines for its use in sheep. It is unknown 
if there are differences in metabolism between horses and sheep, as there are for other 
animals, that could affect efficacy. For example, goats require double the dose of 
anthelmintics given to sheep because goats metabolize anthelmintics faster (University of 
Guelph 2012). As for levamisole, there is no withdrawal time for pyrantel. On Farm 6 in 
2013, the farmer used pyrantel out of desperation, and efficacies were 90% or 97%, 
depending on the formulae used (Jones, personal communication 2014). In 2014, 
levamisole was 100% effective. This is promising since the pre-treatment FEC were very 
high (4500-26 950, n=10). Levamisole is commonly used in sheep in other countries and 
dosage guidelines are available. Levamisole presents a better option to pyrantel.  
This study was the first to use and test closantel in Canada through an Emergency 
Drug Release application. Based on data collected by our research team in 2013, Dr. E. 
Semple and B. Densmore made an application through the Veterinary Drugs Directorate 
to the Federal Ministry of Health for an Emergency Drug Release to import closantel for 
specified clients. On the basis of our results from testing closantel in October 2013, 
closantel is now available to any veterinarian in Canada through the Emergency Drug 
Release process. One other veterinarian in Nova Scotia has since used this process to 
import closantel in 2014. However, closantel is still not licenced. According to FECRTs, 
GIN were resistant to closantel on all five farms tested. This status is misleading because 
closantel kills only H. contortus. Other species are unaffected and continue to lay eggs, 
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reducing the apparent percent efficacy. In October of 2013, the FECRTs on Farms 1 and 
2 showed over 60% and over 86% efficacy, respectively. This provides further support 
for H. contortus being the dominant species in GIN infections in the fall. FEC in 4/14 
lambs in the control group on Farm 1 decreased over the course of the test, which 
reflected GIN becoming hybiotic in the fall. Closantel was tested twice on Farm 1 in 
2014. The first FECRT in July showed 80% to 90% efficacy depending on the formulae, 
and FEC (0-1300, n=11) were reduced well below pathogenic levels for H. contortus 
(5000epg) (Abbott et al. 2012). Even though closantel kills only one species, efficacies 
were higher, and FEC were lower than those of albendazole treated lambs.  
Similarly, post-treatment larval cultures showed that approximately 10% of larvae 
recovered from the closantel group were H. contortus/Cooperia spp.. In the control group 
approximately 70% of larvae recovered were H. contortus/Cooperia spp., FEC were high 
(150-22 300, n=28), and 17/28 lambs had FEC 2000epg. The second FECRT in August 
showed lower efficacies of 70% to 80%. This was expected and is indicative of the 
accumulation of T. circumcincta and Trichostrongylus spp. later in the grazing season, 
rather than AR. The persistent activity of closantel provided excellent worm control of H. 
contortus for several weeks on Farm 1. One month post-treatment, over 90% of larvae 
belonged to other species, and the mean FEC was 200epg. Closantel reduced FEC well 
below pathogenic levels for H. contortus on all five farms. Farms 1, 2, 3, and 5 tested 
closantel in addition to levamisole and ivermectin and/or albendazole. Levamisole was 
the only anthelmintic that outperformed closantel.  
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At the end of September in 2014, a combination of closantel and albendazole was 
tested on Farm 1. When used alone each drug was 70%-80% effective. The combination 
was 100% effective except in one lamb (94B). This lamb had the second lowest pre-
treatment FEC in the treatment group, and given that post-treatment FEC of 0epg were 
obtained for lambs with pre-treatment FEC over 4000epg, it seem likely that this lamb 
missed the dose of one anthelmintic. Nevertheless, the effectiveness of the combination 
confirmed that H. contortus was susceptible to closantel and that other species were still 
susceptible to albendazole.  
4.3 FECRT formulae 
The six FECRT formulae used in this study are effective at identifying AR, when 
the level of resistance is high (Maingi et al. 1996a; Cabaret and Berag 2004). Generally, 
there was agreement in AR status across formulae, but there were great variations in the 
percent efficacies. For example, on Farms 1 and 3 in 2013, efficacies for ivermectin 
ranged from -1222% to 5%, and from -149% to 48%, respectively. When resistance was 
low and/or GIN were susceptible, more consistency was observed in efficacies among 
formulae. These results are similar to those of other studies that compared different 
methods for FECRT calculations (Torgerson et al. 2005; Miller et al. 2006; Falzon et al. 
2014b).  
Falzon et al. (2014b) recommended that in Canada a bias correction term be 
added to all FEC of 0epg and that FECRT4 should be used for research. They also 
recommended that FECRT1 should be used for field testing to reduce costs (fewer 
samples are required), and to allow clinicians to compare results among farms. I disagree 
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with these recommendations. Given the low number of FEC of 0epg observed in this 
study, a bias correction term is unnecessary and “correction” seems inappropriate as it is 
essentially making up data. If a correction term is to be used, it should be added to all 
FEC, not just those of 0epg. It would be better to eliminate lambs with FEC of 0epg from 
the test, or to wait an extra week so that all lambs would be infected. FECRT1 should be 
avoided as it performs poorly when there are large differences in mean FEC between 
control and treatment groups (Calvete and Uriarte 2013). For field use, this may be the 
case because it is unreasonable to leave lambs untreated if they have symptoms of severe 
parasitism. Additionally, in practice it is difficult to get farmers to randomly allocate 
sheep to treatment and/or control groups. According to Dr. G. Jones, without 
encouragement farmers would put healthy looking lambs in the control group, and put 
sickly lambs in the treatment group(s), preferably the levamisole group. Furthermore, 
FECRTs in Nova Scotia have been limited to those conducted by our research group, and 
farmers only pay for the anthelmintic(s). Our group plans to continue providing FECRTs 
as it is unlikely that farmers will absorb the costs of testing elsewhere in the near future. 
Thus, clinicians comparing results among farms and limiting costs are irrelevant. Our 
research group has performed FEC on 4990 samples in the last two years (2013-2014). 
Given that the cost of each FEC is $6.58 at the Veterinary Pathology Laboratory in Truro 
(Jones, personal communication 2015) or up to $20 through a veterinarian, we have saved 
the sheep industry in Nova Scotia between $32 843 and $99 800.  
Of the six FECRT formulae used in this study, I think that iFECRT4 is the most 
appropriate for AR testing in Nova Scotia. A control group is needed to correct for rapid 
increases in FEC during the test, thus providing a better estimate of the true efficacy of 
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the anthelmintic. Also, individually based calculations account for variation in FEC 
among sheep in a group. This is especially important when sample sizes are small. 
iFECRT3, which uses pre- and post-treatment counts from the same treated sheep, is the 
next best option. Although it may not show the true efficacy of the drug, it is sufficient to 
determine if the anthelmintic reduces FEC to a manageable level. FECRT2 should not be 
used. It does not accommodate increases in FEC during the test, variation in FEC among 
sheep, nor variation in FEC among groups. 
In future testing, the inclusion of a control group will have to be decided on a 
farm-by-farm basis. Many flocks in Nova Scotia have 10-20 sheep, so control groups 
may not be feasible (Jones, personal communication 2015). Given the patterns of 
infection on Farm 1 over the last three years, the window of opportunity between FEC 
reaching the threshold for FECRTs and exceeding pathogenic levels is just a few weeks. 
This is also the case in Ontario and Quebec (Mederos et al. 2010). Due to such rapid 
increases in FEC, leaving lambs untreated for one or two more weeks (the length of the 
test) may result in lowered body condition or production losses. For example, during a 
FECRT on Farm 1 in August of 2012, close monitoring of lambs with FAMACHA scores 
was necessary to ensure that they would survive being left untreated for two more weeks. 
FEC of these lambs increased by approximately five times, they suffered a loss of body 
condition, and were anemic by the end of the test (Jones, personal communication 2012). 
On Farm 2, during the second week of August in 2012, 10 lambs died suddenly due to 
haemonchosis, and several others were anemic (Densmore, personal communication 
2013). These lambs were not part of a FECRT, but had gone untreated. Fears of reduced 
weight gain, illness, and deaths due to GIN were the primary reasons why seven of the 13 
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farms tested did not use a control group (Jones, personal communication 2015). These 
fears underscore the severity of the problems with GIN management in Nova Scotia. 
Myriad factors, other than AR, can reduce the efficacy of an anthelmintic. 
Unfortunately, these factors also select for AR. Underdosing has perhaps the greatest 
impact and can result from: failure to calibrate drench guns, incorrect use of the drench 
gun, or using a syringe to administer drugs. An anthelmintic needs to be administered 
over the back of the tongue so that the drug ends up in the rumen, where the drug is 
absorbed and metabolized slowly. When D. Thibault was assisting on Farm 5 in 2013, the 
farmer was observed squirting levamisole onto the sheep’s teeth using a syringe. If an 
anthelmintic is deposited in the front of the mouth sheep can spit out the dose, or it can be 
swallowed into the abomasum where the drug is rapidly absorbed and metabolized. This 
results in GIN not being exposed to an adequate concentration of the drug for the 
necessary period of time (Abbott et al. 2012). Underdosing can also occur when dosages 
are calculated by estimating sheep weights. Conversely, estimating weights can lead to 
overdosing and toxicity with levamisole because it has a low safety margin (University of 
Guelph 2012). 
In this study, anthelmintics were administered correctly, with calibrated drench 
guns, but this is not common on Canadian farms (Falzon et al. 2013c). N. battus eggs 
effectively acted as a control for satisfactory dosing technique in FECRTs. N. battus was 
present in 29/38 pre-treatment groups. For anthelmintics other than closantel post-
treatment FEC of N. battus were 0epg in 21/25 groups. Of the four post-treatment groups 
with N. battus, three had a single sheep, and one had two sheep, with N. battus FEC of 
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50-200epg. Two of these groups were from Farm 3, where dosages were calculated by 
estimating the weight of the heaviest sheep. Underdosing may have occurred on this 
farm. On Farm 1, two lambs in the moxidectin group had N. battus post-treatment. 
Treatment with moxidectin involves a 1mL/50kg dose, so it is very easy to underdose 
lambs and for sheep to fail to swallow the whole dose. The FEC of 0epg of N. battus in 
the majority of groups indicated that there was no resistance in this species and confirmed 
that the dosing technique was acceptable. In future FECRTs, where farmers may be 
treating sheep themselves, N. battus could be used as an informal method for confirming 
correct dosing.  
4.4 Anthelmintic combinations and refugia 
Combinations of anthelmintics, with different modes of action, are increasingly 
being used to control GIN where AR is present to one or more anthelmintic(s). 
Combination formulations are available in Australia, New Zealand, and the United 
Kingdom (Geary et al. 2012). The literature abounds with studies reporting the successful 
use of anthelmintic combinations against AR GIN, and they have been used for many 
years (Maingi et al. 2002; Baker et al. 2012; Geurden et al. 2012; Geary et al. 2012; 
Leathwick and Besier 2014). Mathematical modeling has shown that using a combination 
of drugs delays the development of AR to both constituents, and is superior to rotations 
of single anthelmintics. The higher the efficacies of both drugs, the longer it takes for AR 
to develop to a detectable level (Barnes et al. 1995; Learmount et al. 2012; Leathwick 
2012; Dobson et al. 2011). Except for a few mutations that confer resistance to either 
benzimidazoles or ivermectin, which are thought to act dominantly (Kotze et al. 2014), 
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alleles for resistance are generally considered to be recessive. Each drug protects the 
efficacy of the other because initial frequencies of resistance alleles are low and most are 
hidden in heterozygotes. Hence, there are very few doubly resistant survivors. Resistant 
worms are likely to mate with worms that are susceptible to both drugs, thus preserving 
susceptibility in the next generation (Bartram 2013). A recent field trial has corroborated 
the results of modelling studies (Leathwick et al. 2012). More field trials are needed to 
gauge the long-term performance of anthelmintic combinations under typical farm 
conditions.  
Derquantel belongs to the newest class of anthelmintics, the spiroindoles, and is 
available only as a dual active with abamectin called STARTECT. According to a 
simulation study by Learmount et al. (2012) resistance to derquantel was negligible after 
20 years of continuous use, even when the efficacy of abamectin was 50%, provided that 
refugia are high. High refugia involved low stocking density, grazing lambs separately 
from ewes, targeted treatment of lambs with high FEC, and no treatment of ewes. When 
the efficacy of abamectin was 50% and refugia was low, STARTECT was highly 
effective for five years, after which AR developed rapidly to derquantel and the efficacy 
of abamectin dropped to 0%.  
In the Learmount et al. (2014) simulation study, the maintenance of the low 
efficacy of abamectin and the high efficacy of derquantel in a high refugia environment is 
promising. Considering the AR identified in this study, the ideal situation where both 
drugs in a combination are highly effective is unlikely to be realized. In a combination, 
both anthelmintics should have a similar duration of activity, so that throughout exposure, 
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only doubly resistant GIN survive treatment. Moxidectin and closantel have persistent 
activity, whereas levamisole’s duration of activity is short. Compromises will need to be 
made on which anthelmintics to use in combinations. Multidrug resistance needs to be 
investigated so that farmers can make informed decisions on the best anthelmintics to 
administer. For example, on Farms 1, 8, and 12, percent efficacies of albendazole are 
high enough for it to be used in combination with another drug. Importantly, when the 
efficacy of both anthelmintics in the combination is less than about 70%, the ability of 
each anthelmintic to protect the efficacy of the other is greatly diminished (Leathwick et 
al. 2012). Therefore, this study is timely because we have access to a few highly effective 
anthelmintics. Levamisole and moxidectin are effective against all GIN, and closantel is 
effective against H. contortus. One or more of these anthelmintics could be used in 
combination with lower efficacy drugs on farms with AR. It should be specified that 
since multi-active formulations are not available in Canada, using anthelmintics in 
combination involves administering the full dose of each drug sequentially, not mixing 
them together (Abbott et al. 2012).  
Increasing transparency about the use of anthelmintics among farmers would be a 
great benefit to farmers and the sheep industry. Currently, such communication between 
farmers selling and buying sheep in Nova Scotia is lacking (author’s observation). 
Knowing the efficacy of anthelmintics on source farms would help farmers buying sheep 
to decide which anthelmintics to use in quarantine treatments, or at least convince them 
that quarantine treatments are necessary. Most farmers do not quarantine incoming sheep 
and those who do typically use only one anthelmintic (Falzon et al. 2013c; Jones, 
personal communication 2014). Since almost all farms use either a macrocyclic lactone or 
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a benzimidazole, there is a 50/50 chance that new sheep will be treated in quarantine with 
a drug from the same group as was used on the source farm, to which GIN are likely 
resistant. Anthelmintic combinations would be highly beneficial to quarantine treatments, 
and are recommended (Abbott et al. 2012). 
The preservation of a refugia population of susceptible GIN is fundamental to the 
successful and sustainable incorporation of anthelmintic combinations in worm 
management (Besier 2012). This can be achieved by leaving some sheep untreated. The 
proportion of sheep that need to be left untreated depends on the level of AR (Barnes et 
al. 1995). With a higher level of AR, a greater proportion of sheep need to be left 
untreated (Barnes et al. 1995). This leads to the difficult situation where farmers must 
balance reducing treatments without compromising sheep health. What’s more, it 
necessitates that farmers accept living with parasitism rather than trying to eliminate it.  
Leathwick et al. (2012) determined that leaving 10% of lambs untreated when an 
anthelmintic is 95% effective can slow the development of AR. However, farmers in 
Nova Scotia may be unable to get through an entire grazing season without dosing all 
lambs at least once. For example, on Farm 1 no lambs would have survived without 
treatment in 2013, and just four lambs went without treatment in 2014. Leaving a portion 
of ewes untreated is a better alternative (Dobson et al. 2011a, 2011b). The above 
mentioned studies attempted to quantify the parameters for adequate refugia, but each 
farm is unique so quantifications are not broadly applicable. The general message can be 
boiled down to: for best results, treat as few sheep as possible.  
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Preserving susceptible H. contortus from one season to the next can only be 
achieved thorough hypobiotic larvae within ewes that have not recently been exposed to 
anthelmintics. Hence, ewes are the key to refugia. Anthelmintic use can be reduced with 
targeted selective treatment, which involves identifying and treating only sheep that need 
it (Kenyon et al. 2009; Besier et al. 2010; Learmount et al. 2015). This can circumvent 
the risk of disease inherent in leaving a certain proportion of the flock untreated and has 
been shown to reduce anthelmintic treatment by up to 50% (Busin et al. 2013). The 
FAMACHA system is an excellent tool for identifying anemic sheep that need 
treatment for infections with H. contortus (van Wyk and Bath 2002). The FAMACHA  
system has been validated in the United States and thousands of farmers there have been 
trained to use this system at workshops (Terrill et al. 2012). FAMACHA has been 
readily adopted because it is easy to learn and employ. Several farmers in Nova Scotia 
have been provided with FAMACHA cards at workshops.  
4.5 Grazing management to reduce treatment frequency 
Non-drug worm management strategies can reduce the need for anthelmintic 
treatment, thereby reducing the selection pressure for resistant GIN (Abbott et al. 2012). 
Grazing lambs separately from ewes was an excelllent strategy to limit infections with H. 
contortus and lambs grazed without ewes in 2014 were never treated. The simplicity and 
cost effectivenss of this strategy may be acceptable to farmers, particularly to those who 
have resorted to raising lambs in the barn. In the face of unmanageable AR H. contortus, 
lambs could be raised on pasture where forage is freely available. Other AR GIN could 
be managed too, because infections would be limited to those arising from overwintered 
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L3s. Additionally, preventative treatments of ewes and lambs, to reduce pasture 
contamination and subsequently prevent high worm burdens in lambs, would not be 
needed. This would help to maintain a refugia population of susceptible GIN in ewes 
from year-to-year.  
The results of the larval culture from the only lambs group were unexpected. Over 
30% of larvae recovered were H. contortus/Cooperia spp.. Correct labeling of the 
samples was confirmed, and through consultation with the shepherd of the flock it was 
discovered that two of the lambs in the only lambs group repeatedly escaped under the 
fence and grazed in the pasture with lambs and ewes (Hines, personal communication 
2014). These two lambs consistently had higher FEC than the rest of their group. Feces 
from one of these lambs was part of the composite larval culture. It is likely that the H. 
contortus/Cooperia spp. came from this lamb, or from lambs infected from eggs shed by 
the escapees. The two escapee lambs inadvertently supplied the rest of the lambs in their 
group with exposure to H. contortus, but low infection levels were maintained. 
Lambs need continual exposure to GIN to develop and maintain acquired 
immunity (Abbott et al. 2012). While immunity may be unnecessary for market lambs, 
immunity is essential for lambs that remain for breeding. Seeding a pasture of only lambs 
with GIN eggs from other sheep could provide adequate exposure for immune 
development without lambs facing high rates of larval challenge that could lead to 
clinical illness. Due to H. contortus’s high biotic potential, this strategy is not as easy as 
it seems. For example, in 2013 two ewe lambs went from the lambing barn to a clean ¼ 
acre paddock.  The ewe lambs shared their paddock with one other lamb for 10 days in 
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July. By the end of the grazing season the ewe lambs were anemic and one had a FEC 
over 33 000epg (Jones 2013). In 10 days, the other lamb had heavily contaminated the 
pasture with H. contortus. An intentional and controlled seeding of GIN on pasture where 


















In this study, AR was present and in some cases severe. A transition to using 
anthelmintics in combination is vital to preserve the efficacy of available drugs and to 
provide adequate worm control. Multidrug resistance needs to be investigated and routine 
FECRTs are essential to monitor anthelmintic efficacy. Closantel is an excellent option 
for controlling resistant H. contortus and levamisole or moxidectin are suitable options 
where several species are resistant. It has been standard practice for many years to treat 
whole flocks in winter and/or at turnout (Falzon et al. 2013c; Jones, personal 
communication 2014). This has undoubtedly contributed greatly to the rapid development 
of AR in H. contortus. A paradigm shift from preventative whole flock treatments in the 
fall and winter to targeted treatments and the incorporation of non-drug worm 
management strategies to preserve refugia is desperately needed. Without such changes, 
sheep farming is unsustainable.  
It is likely that the use of unlicensed anthelmintics and closantel will become a 
mainstay in worm management in Nova Scotia. A major limitation to GIN management 
in Canada is that few drug groups are available. While effective anthelmintics should not 
be held in reserve until other drugs fail, we must dissuade farmers from switching to the 
use of a highly effective drug as the sole means of controlling GIN. Bringing in a new 
drug without implementing changes to farming practices would be a very short-term 
solution. Monepantel, the first anthelmintic in a new group called the amino-acetonitrile 
derivatives, was introduced in the Netherlands in 2011. After two years of use on one 
farm, H. contortus had developed AR to monepantel, and a FECRT showed that efficacy 
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was 0%. The farmer did not think that other anthelmintics were effective and switched to 
frequently using solely monepantel (Van den Brom et al. 2015). The Van den Brom 
(2015) study highlights exactly the type of situation that we do not want to occur in 
Canada. The limited availability of levamisole, through a veterinary compounding 
pharmacy, and to closantel, via the Emergency Drug Release process, provides an 
opportunity for farmers to be educated about the drugs’ sustainable use. For a farmer to 
access closantel, a veterinarian with whom the farmer has a Veterinarian-Client 
Professional Relationship (VCPR) must submit an application for an Emergency Drug 
Release. Currently, farmer outreach is insufficient, and educating farmers about GIN is 
exceedingly difficult when farmers are unaware that they have a problem.  
Based on the results of this study, the challenges ahead seem daunting, but this 
situation is in no way unique. Indeed, Nova Scotia is similar to everywhere else that has 
investigated AR, particularly regions with cold winters where H. contortus has become a 
major problem (Maingi et al. 1996b; Höglund et al. 2009; Domke et al. 2012a, 2012b; 
Groz et al 2013; Peña-Espinoza et al. 2014). Developing an organized and accessible 
sustainable management education program for farmers could help achieve the necessary 
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Table A1. Guideline for the interpretation of FEC. Modified from: Abbott et al. (2012). 
Species contributing to infection Infection Level (epg) 
Low Medium High 
Mixed ( no H. contortus) 250 250-750 750 
Mixed ( with H. contortus)  500-1500 
H. contortus  1000-5000 
T. circumcinta  500-1500 
Trichostrongylus spp.  500-1500 















Table A2. Anthelmintic drug groups used against GIN (Abbott et al. 2012; University of 
Guelph 2012). 
Drug group Chemical 
name(s) 
Spectrum Accessible 































































Monepantel Broad -  
Spiroindoles Dual-active of 
derquantel 
and abamectin 
Broad -  
Salicylanilides 








Access to all drugs requires a prescription from a veterinarian  
*Levamisole is available only through a compounding veterinary pharmacy  
** Closantel is available only through the Emergency Drug Release process by veterinary 











Figure B1. Two-chamber McMaster counting slide used for FEC floatation of ruminant 
feces (Chalex Corporation, USA). 
 
Figure B2. GIN eggs observed within the grid lines of a McMaster counting slide, at 






Figure B3. Strongyle-type eggs found in sheep feces, which cannot be differentiated by 
microscopy, at 100x magnification. These could be eggs of: H. contortus,                        
T. circumcincta, Trichostrongylus spp., C. ovina, Cooperia spp., Bunostomum spp., 
and/or Oesophagostomum spp.. If this density of eggs was observed within the grids of 








Figure B4. S. papillosus egg (yellow oval) next to a strongyle-type egg, at 100x 
magnification (expanded). 
 
Figure B5. N. battus egg (blue rectangle), S. papillosus egg (yellow oval), and strongyle-




Figure B6. N. battus egg (blue rectangle) and N. filicollis eggs (green oval), at 100x 
magnification.  
 
Figure B7. N. battus egg (blue rectangle), N. filicollis eggs (green oval), and strongyle-




Figure B8. Developing larva inside a strongyle-type egg, at 400x magnification. 
  
Figure B9. N. filicollis egg containing an early-stage embryo, at 400x magnification.
 
 
Table B1. Example of data sheet used to record FEC.   
    FARM ID:                                                                       RECIEVED:                                                           PAGE #        OF 
    DATE COLLECTED:                                                       ANALYZED:                 
FCS Animal ID Sex Age Category FAMACHA Raw GIN Raw N. b EPG GIN EPG N. b 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
   Age = L/Y/A lamb/yearling/adult     Category = C control, TC treat Closantel, TI Ivermectin, TL levamisole,  








Figure B10. Variation in head shape of L3s, at 400x magnification. Shape can range 
from obviously round (top left) to obviously square (top right), and from narrow (bottom 











Figure B11. Variation in tail-sheath-length of L3s, at 400x magnification. Red arrows 
indicate the sheath of the larvae. From left to right (top): X=1.0, X=1.7, X=2.5, X=4.1, 





Figure B12. Gut cell shape of L3s. Rectangular (left) and triangular (right), at 400x 




Figure B13. Variation in body width of L3s. Narrow (H. contortus) and wide (C. ovina) 




Figure B14. N. battus larva recovered from a seven week-old larval culture from Farm 8, 







Figure B15. Composite photo of a N. battus larva recovered from a seven week-old 
larval culture from Farm 8. The nucleus inside each of the eight gut cells is visible as a 




Figure B16. Head and tail of H. contortus, at 400x magnification. 
 
Figure B17. GIN with 16 triangular gut cells, at 100x magnification. The nucleus in each 





Figure B18. H. contortus (black arrow) and T. circumcinta/Trichostrongylus spp. (red 




Figure B19. Short, medium, and long tailed GIN. Short: T. circumcinta/Trichostrongylus 




     Table B2. Example of data sheet used to record morphological characteristics of L3s.  
                             FARM ID:                                                  ANALYZED:                                                                         PAGE #        OF 
                        DATE OF CULTURE:                                 DRUG GROUP:                                                       
 Shape (length, 
width, 
straight/curved) 
Sheath-length Filament? Head 
shape 






       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
1
1
4
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